全球免疫诊断市场

预计到 2030 年全球免疫诊断市场规模将达 299 亿美元

全球免疫诊断市场规模在 2024 年估计为 246 亿美元，预计到 2030 年将达到 299 亿美元，2024 年至 2030 年的复合年增长率为 3.3%。免疫诊断试剂是该报告中分析的细分市场之一，预计其复合年增长率为 3.9%，在分析期结束时达到 168 亿美元。在分析期内，免疫诊断仪器部分预计将以 2.7% 的复合年增长率成长。

美国市场预计将达到 67 亿美元，中国市场复合年增长率将达到 6.3%

预计 2024 年美国免疫诊断市场规模将达 67 亿美元。作为世界第二大经济体的中国，预计到 2030 年市场规模将达到 60 亿美元，2024-2030 年分析期内的复合年增长率为 6.3%。其他值得注意的区域市场包括日本和加拿大，预计在分析期间的复合年增长率分别为 1.3% 和 2.6%。在欧洲，德国的复合年增长率预计为 1.9%。

全球免疫诊断市场—主要趋势与驱动因素摘要

为什么免疫诊断对于早期疾病检测和监测至关重要？

免疫诊断是一种基于实验室的诊断技术，利用抗原抗体交互作用来检测和量化患者样本（如血液、尿液和唾液）中的生物标记。这些测试对于诊断感染疾病、自体免疫疾病、荷尔蒙失调、癌症和过敏至关重要。这些测试由于其高特异性、敏感性和快速的周转时间而被广泛应用于医院、诊断实验室和研究机构。随着医疗保健系统越来越重视预防性诊断和早期疗育，免疫诊断工具正在成为现代医学检测的基石。

它们的效用涵盖定性和定量应用，从酵素结合免疫吸附检测法(ELISA) 和化学冷光免疫检测(CLIA) 到用于即时检验的横向流动免疫检测。随着对分散诊断和家庭健康监测的需求不断增长，免疫诊断也被整合到紧凑的平台和多路復用测试格式中，使其在临床和临床前环境中更易于使用和高效。

技术进步如何提高测试的准确性和速度？

由于检测化学、生物感测器设计和检测系统的进步，免疫诊断市场正在迅速转变。高通量自动分析仪、奈米材料增强免疫检测和数位免疫检测平台正在显着提高测试灵敏度和多路復用能力。这些创新使得从单一检体同时检测多种生物标记成为可能，这在癌症筛检、自体免疫分析和感染疾病检测中特别有益。

此外，智慧型手机连接设备和微流体实验室晶片技术正在扩大照护现场应用，尤其是在资源有限的环境中。人工智慧主导的演算法正在整合到诊断软体中，以提高解释准确性和临床决策能力。此外，萤光、电化学和光学检测技术的结合正在提高免疫诊断工具的分析性能，增强个人化和精准医疗的相关性。

哪些应用和地区推动了免疫诊断测试的需求？

主要临床应用包括感染疾病诊断（例如 HIV、肝炎、COVID-19）、肿瘤标记（例如 PSA、CA125）、心血管风险分析（例如肌钙蛋白）和自体免疫组（例如 ANA、类风湿因子）。医院和诊断实验室仍然是最大的最终用户，其次是居家医疗、学术研究中心和生物製药公司。慢性病管理和术后监测对免疫诊断测试的需求尤其强烈。

北美主要由大型诊断公司、高额医疗保健支出和强有力的法律规范组成。欧洲也纷纷效仿，越来越重视预防性诊断和筛检计画。亚太地区是成长最快的地区，这得益于中国和印度等国家医疗保健服务的改善、早期诊断意识的增强以及保险覆盖范围的扩大。随着基础设施和疾病监测计画的改善，非洲和拉丁美洲的采用率也不断提高。

免疫诊断市场的成长受到多种因素的推动…

免疫诊断市场的成长受到多种因素的推动，包括全球慢性病和感染疾病的增加、检测自动化和灵敏度的进步以及对快速准确诊断的需求不断增加。多重免疫测量、实验室晶片系统和人工智慧测试平台等技术改进正在扩大其在临床和照护现场中的应用。新生物标誌物和检测套组的监管核准也促进了市场扩张。

从最终用途的角度来看，家庭检测的兴起、个人化医疗投资的增加以及免疫诊断与药物开发工作流程的整合正在推动需求。政府筛检计画（尤其是在肿瘤学和感染疾病领域）以及分散实验室网路的扩展也是主要的成长要素。随着诊断准确性在现代医​​疗保健中变得越来越重要，免疫诊断将继续成为全球实验室医学的基石。

部分

产品类型（试剂、仪器、软体和服务）、技术（酵素结合免疫吸附检测法、化学冷光免疫检测、萤光免疫分析、放射免疫检测、其他技术）、应用（感染疾病、肿瘤学和内分泌学、骨骼和矿物质疾病、自体免疫疾病、心臟生物标记、药物监测、其他应用）、最终用途（医院、临床实验室、学术和研究实验室、其他最终用途）

受访公司范例（值得关注的34家公司）

• Abbott Laboratories
• Agilent Technologies, Inc.
• bioMerieux SA
• Bio-Rad Laboratories Inc.
• Cepheid
• DiaSorin SpA
• Erba Diagnostics Mannheim GmbH
• F. Hoffmann-La Roche AG
• Grifols, SA
• Guardant Health
• Illumina, Inc.
• Immunodiagnostic Systems Holdings PLC
• Inova Diagnostics, Inc.
• Johnson & Johnson
• NeoGenomics Laboratories
• Quest Diagnostics Incorporated
• Siemens Healthineers AG
• Sysmex Corporation
• Thermo Fisher Scientific Inc.
• Trinity Biotech plc

关税影响係数

全球产业分析师根据公司总部所在国家、製造地以及进出口（成品和OEM）预测公司竞争地位的变化。这种复杂且多方面的市场动态预计将以多种方式影响竞争对手，包括人为提高销货成本、降低盈利、重组供应链等微观和宏观市场动态。

全球产业分析师密切关注世界领先的首席经济学家（14,949）、智库（62）和贸易及产业协会（171）的专家意见，以评估生态系统的影响并应对新的市场现实。各主要国家的专家和经济学家都在关注关税及其对国家的影响。

全球产业分析师预计，这种动盪将在未来几个月内平息，新的世界秩序将更加明确地建立。全球产业分析师正在即时追踪这些发展。

2025年4月：谈判阶段

我们四月份的发布将涵盖关税对全球市场整体的影响，并为各地区的市场调整提供指导。我们的预测是基于历史数据和不断发展的市场影响因素。

2025年7月：最终关税调整

免费更新 在各国宣布最终重置后，本公司的客户将在 7 月收到免费更新。最终更新包含明确的关税影响分析。

相互和双边贸易及关税影响分析：

美国<>中国<>墨西哥<>加拿大<>欧盟<>日本<>印度<>其他176个国家

领先的产业经济学家：全球产业分析师知识库追踪 14,949 位经济学家，其中包括来自民族国家、智库、贸易和产业协会、大型企业和领域专家的最具影响力的首席经济学家，他们共用了全球经济状况这一前所未有的模式转移的影响。我们的 16,491 多份报告中的大多数都遵循这个基于两阶段里程碑的发布计划。

目录

第一章调查方法

第二章执行摘要

• 市场概览
• 主要企业
• 市场趋势和驱动因素
• 全球市场展望

第三章市场分析

• 美国
• 加拿大
• 日本
• 中国
• 欧洲
• 法国
• 德国
• 义大利
• 英国
• 西班牙
• 俄罗斯
• 其他欧洲国家
• 亚太地区
• 澳洲
• 印度
• 韩国
• 其他亚太地区
• 拉丁美洲
• 阿根廷
• 巴西
• 墨西哥
• 其他拉丁美洲
• 中东
• 伊朗
• 以色列
• 沙乌地阿拉伯
• 阿拉伯聯合大公国
• 其他中东地区
• 非洲

第四章 比赛

Global Immunodiagnostics Market to Reach US$29.9 Billion by 2030

The global market for Immunodiagnostics estimated at US$24.6 Billion in the year 2024, is expected to reach US$29.9 Billion by 2030, growing at a CAGR of 3.3% over the analysis period 2024-2030. Immunodiagnostics Reagents, one of the segments analyzed in the report, is expected to record a 3.9% CAGR and reach US$16.8 Billion by the end of the analysis period. Growth in the Immunodiagnostics Instruments segment is estimated at 2.7% CAGR over the analysis period.

The U.S. Market is Estimated at US$6.7 Billion While China is Forecast to Grow at 6.3% CAGR

The Immunodiagnostics market in the U.S. is estimated at US$6.7 Billion in the year 2024. China, the world's second largest economy, is forecast to reach a projected market size of US$6.0 Billion by the year 2030 trailing a CAGR of 6.3% over the analysis period 2024-2030. Among the other noteworthy geographic markets are Japan and Canada, each forecast to grow at a CAGR of 1.3% and 2.6% respectively over the analysis period. Within Europe, Germany is forecast to grow at approximately 1.9% CAGR.

Global Immunodiagnostics Market - Key Trends & Drivers Summarized

Why Are Immunodiagnostics Critical in Early Disease Detection and Monitoring?

Immunodiagnostics are laboratory-based diagnostic techniques that utilize antigen-antibody interactions to detect and quantify biomarkers in patient samples such as blood, urine, or saliva. These tests are crucial in diagnosing infectious diseases, autoimmune disorders, hormonal imbalances, cancer, and allergies. They are widely used in hospitals, diagnostic laboratories, and research institutions for their high specificity, sensitivity, and rapid turnaround time. As healthcare systems focus on preventive diagnostics and early intervention, immunodiagnostic tools are becoming foundational in modern medical testing.

Their utility spans both qualitative and quantitative applications, ranging from enzyme-linked immunosorbent assays (ELISA) and chemiluminescent immunoassays (CLIA) to lateral flow immunoassays used in point-of-care testing. With increasing demand for decentralized diagnostics and home-based health monitoring, immunodiagnostics are also being integrated into compact platforms and multiplexed test formats, making them more accessible and efficient in both clinical and non-clinical settings.

How Are Technological Innovations Enhancing Test Accuracy and Speed?

The immunodiagnostics market is undergoing rapid transformation through advancements in assay chemistry, biosensor design, and detection systems. High-throughput automated analyzers, nanomaterial-enhanced immunoassays, and digital immunoassay platforms are significantly improving test sensitivity and multiplexing capabilities. These innovations are allowing for the simultaneous detection of multiple biomarkers from a single sample, which is particularly beneficial in cancer screening, autoimmune profiling, and infectious disease panels.

Additionally, smartphone-linked devices and microfluidic lab-on-chip technologies are expanding point-of-care applications, especially in resource-limited settings. AI-driven algorithms are being integrated into diagnostic software to improve interpretation accuracy and clinical decision-making. Moreover, the incorporation of fluorescence, electrochemical, and photonic detection techniques is enhancing the analytical performance of immunodiagnostic tools, making them more reliable for personalized and precision medicine.

Which Applications and Regions Are Driving Demand for Immunodiagnostic Testing?

Key clinical applications include infectious disease diagnostics (e.g., HIV, hepatitis, COVID-19), oncology markers (e.g., PSA, CA125), cardiovascular risk profiling (e.g., troponins), and autoimmune panels (e.g., ANA, rheumatoid factor). Hospitals and diagnostic labs remain the largest end-users, followed by home healthcare, academic research centers, and biopharmaceutical companies. The demand for immunodiagnostic testing is especially strong in chronic disease management and post-surgical monitoring.

North America dominates due to the presence of leading diagnostic firms, high healthcare spending, and a strong regulatory framework. Europe follows with growing emphasis on preventive diagnostics and screening programs. Asia-Pacific is the fastest-growing region, driven by rising healthcare access in countries like China and India, increasing awareness of early diagnosis, and expanding insurance coverage. Africa and Latin America are also seeing growing adoption as infrastructure and disease surveillance programs improve.

The Growth in the Immunodiagnostics Market Is Driven by Several Factors…

The growth in the immunodiagnostics market is driven by several factors including the global rise in chronic and infectious diseases, advances in assay automation and sensitivity, and increasing demand for rapid and accurate diagnostics. Technological improvements in multiplex immunoassays, lab-on-chip systems, and AI-enhanced test platforms are expanding both clinical and point-of-care use. Regulatory approvals for new biomarkers and test kits are also contributing to market expansion.

From an end-use perspective, the rising adoption of home-based testing, growing investment in personalized medicine, and the integration of immunodiagnostics in drug development workflows are fueling demand. Government screening programs, especially in oncology and infectious diseases, and the expansion of decentralized lab networks are also key growth contributors. As diagnostic precision becomes increasingly vital in modern healthcare, immunodiagnostics will continue to be a cornerstone of laboratory medicine worldwide.

SCOPE OF STUDY:

The report analyzes the Immunodiagnostics market in terms of units by the following Segments, and Geographic Regions/Countries:

Segments:

Product Type (Reagents, Instruments, Software & Services); Technology (Enzyme-linked Immunosorbent Assay, Chemiluminescence Immunoassay, Fluorescent Immunoassay, Radioimmunoassay, Other Technologies); Application (Infectious Diseases, Oncology & Endocrinology, Bone & Mineral Diseases, Autoimmune Disorders, Cardiac Biomarkers, Drug Monitoring, Other Applications); End-Use (Hospitals, Clinical Laboratories, Academic & Research Institutes, Other End-Uses)

Geographic Regions/Countries:

World; United States; Canada; Japan; China; Europe (France; Germany; Italy; United Kingdom; Spain; Russia; and Rest of Europe); Asia-Pacific (Australia; India; South Korea; and Rest of Asia-Pacific); Latin America (Argentina; Brazil; Mexico; and Rest of Latin America); Middle East (Iran; Israel; Saudi Arabia; United Arab Emirates; and Rest of Middle East); and Africa.

Select Competitors (Total 34 Featured) -

• Abbott Laboratories
• Agilent Technologies, Inc.
• bioMerieux SA
• Bio-Rad Laboratories Inc.
• Cepheid
• DiaSorin S.p.A.
• Erba Diagnostics Mannheim GmbH
• F. Hoffmann-La Roche AG
• Grifols, S.A.
• Guardant Health
• Illumina, Inc.
• Immunodiagnostic Systems Holdings PLC
• Inova Diagnostics, Inc.
• Johnson & Johnson
• NeoGenomics Laboratories
• Quest Diagnostics Incorporated
• Siemens Healthineers AG
• Sysmex Corporation
• Thermo Fisher Scientific Inc.
• Trinity Biotech plc

TARIFF IMPACT FACTOR

Our new release incorporates impact of tariffs on geographical markets as we predict a shift in competitiveness of companies based on HQ country, manufacturing base, exports and imports (finished goods and OEM). This intricate and multifaceted market reality will impact competitors by artificially increasing the COGS, reducing profitability, reconfiguring supply chains, amongst other micro and macro market dynamics.

We are diligently following expert opinions of leading Chief Economists (14,949), Think Tanks (62), Trade & Industry bodies (171) worldwide, as they assess impact and address new market realities for their ecosystems. Experts and economists from every major country are tracked for their opinions on tariffs and how they will impact their countries.

We expect this chaos to play out over the next 2-3 months and a new world order is established with more clarity. We are tracking these developments on a real time basis.

As we release this report, U.S. Trade Representatives are pushing their counterparts in 183 countries for an early closure to bilateral tariff negotiations. Most of the major trading partners also have initiated trade agreements with other key trading nations, outside of those in the works with the United States. We are tracking such secondary fallouts as supply chains shift.

To our valued clients, we say, we have your back. We will present a simplified market reassessment by incorporating these changes!

APRIL 2025: NEGOTIATION PHASE

Our April release addresses the impact of tariffs on the overall global market and presents market adjustments by geography. Our trajectories are based on historic data and evolving market impacting factors.

JULY 2025 FINAL TARIFF RESET

Complimentary Update: Our clients will also receive a complimentary update in July after a final reset is announced between nations. The final updated version incorporates clearly defined Tariff Impact Analyses.

Reciprocal and Bilateral Trade & Tariff Impact Analyses:

USA <> CHINA <> MEXICO <> CANADA <> EU <> JAPAN <> INDIA <> 176 OTHER COUNTRIES.

Leading Economists - Our knowledge base tracks 14,949 economists including a select group of most influential Chief Economists of nations, think tanks, trade and industry bodies, big enterprises, and domain experts who are sharing views on the fallout of this unprecedented paradigm shift in the global econometric landscape. Most of our 16,491+ reports have incorporated this two-stage release schedule based on milestones.

COMPLIMENTARY PREVIEW

Contact your sales agent to request an online 300+ page complimentary preview of this research project. Our preview will present full stack sources, and validated domain expert data transcripts. Deep dive into our interactive data-driven online platform.

TABLE OF CONTENTS

I. METHODOLOGY

II. EXECUTIVE SUMMARY

• 1. MARKET OVERVIEW
  • Influencer Market Insights
  • World Market Trajectories
  • Impact of Covid-19 and a Looming Global Recession
  • Immunodiagnostics - Global Key Competitors Percentage Market Share in 2025 (E)
  • Competitive Market Presence - Strong/Active/Niche/Trivial for Players Worldwide in 2025 (E)
• 2. FOCUS ON SELECT PLAYERS
• 3. MARKET TRENDS & DRIVERS
  • Rising Global Prevalence of Infectious and Chronic Diseases Drives Demand for Immunodiagnostic Testing
  • Increased Use of Immunoassays in Oncology and Autoimmune Disease Detection Expands Market Scope
  • Technological Advancements in Chemiluminescence and ELISA Platforms Enhance Sensitivity and Speed
  • Point-of-Care Immunodiagnostics Gain Momentum With Growth in Decentralized Testing Models
  • Integration of AI and Machine Learning Improves Accuracy and Interpretation of Immunoassay Results
  • Growing Demand for Early Disease Screening Programs Spurs Adoption in Preventive Diagnostics
  • Expansion of Home Testing Kits and Wearable Immuno-Biomarkers Drives Direct-to-Consumer Growth
  • Emergence of Multiplexed Immunodiagnostic Platforms Enables Simultaneous Disease Detection
  • Rise in Companion Diagnostics Supports Personalized Therapy Selection in Immuno-Oncology
  • Miniaturization and Lab-on-Chip Technologies Expand Applications in Resource-Limited Settings
  • Hospital Automation and LIS Integration Enhance Workflow Efficiency for High-Throughput Testing
  • Increasing Geriatric Population With Comorbidities Accelerates Demand for Broad-Spectrum Diagnostic Panels
• 4. GLOBAL MARKET PERSPECTIVE
  • TABLE 1: World Immunodiagnostics Market Analysis of Annual Sales in US$ Million for Years 2015 through 2030
  • TABLE 2: World Recent Past, Current & Future Analysis for Immunodiagnostics by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2024 through 2030 and % CAGR
  • TABLE 3: World Historic Review for Immunodiagnostics by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 4: World 15-Year Perspective for Immunodiagnostics by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets for Years 2015, 2025 & 2030
  • TABLE 5: World Recent Past, Current & Future Analysis for Reagents by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2024 through 2030 and % CAGR
  • TABLE 6: World Historic Review for Reagents by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 7: World 15-Year Perspective for Reagents by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2015, 2025 & 2030
  • TABLE 8: World Recent Past, Current & Future Analysis for Instruments by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2024 through 2030 and % CAGR
  • TABLE 9: World Historic Review for Instruments by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 10: World 15-Year Perspective for Instruments by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2015, 2025 & 2030
  • TABLE 11: World Recent Past, Current & Future Analysis for Software & Services by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2024 through 2030 and % CAGR
  • TABLE 12: World Historic Review for Software & Services by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 13: World 15-Year Perspective for Software & Services by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2015, 2025 & 2030
  • TABLE 14: World Recent Past, Current & Future Analysis for Oncology & Endocrinology by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2024 through 2030 and % CAGR
  • TABLE 15: World Historic Review for Oncology & Endocrinology by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 16: World 15-Year Perspective for Oncology & Endocrinology by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2015, 2025 & 2030
  • TABLE 17: World Recent Past, Current & Future Analysis for Bone & Mineral Diseases by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2024 through 2030 and % CAGR
  • TABLE 18: World Historic Review for Bone & Mineral Diseases by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 19: World 15-Year Perspective for Bone & Mineral Diseases by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2015, 2025 & 2030
  • TABLE 20: World Recent Past, Current & Future Analysis for Autoimmune Disorders by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2024 through 2030 and % CAGR
  • TABLE 21: World Historic Review for Autoimmune Disorders by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 22: World 15-Year Perspective for Autoimmune Disorders by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2015, 2025 & 2030
  • TABLE 23: World Recent Past, Current & Future Analysis for Cardiac Biomarkers by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2024 through 2030 and % CAGR
  • TABLE 24: World Historic Review for Cardiac Biomarkers by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 25: World 15-Year Perspective for Cardiac Biomarkers by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2015, 2025 & 2030
  • TABLE 26: World Recent Past, Current & Future Analysis for Drug Monitoring by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2024 through 2030 and % CAGR
  • TABLE 27: World Historic Review for Drug Monitoring by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 28: World 15-Year Perspective for Drug Monitoring by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2015, 2025 & 2030
  • TABLE 29: World Recent Past, Current & Future Analysis for Other Applications by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2024 through 2030 and % CAGR
  • TABLE 30: World Historic Review for Other Applications by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 31: World 15-Year Perspective for Other Applications by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2015, 2025 & 2030
  • TABLE 32: World Recent Past, Current & Future Analysis for Infectious Diseases by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2024 through 2030 and % CAGR
  • TABLE 33: World Historic Review for Infectious Diseases by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 34: World 15-Year Perspective for Infectious Diseases by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2015, 2025 & 2030
  • TABLE 35: World Recent Past, Current & Future Analysis for Hospitals by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2024 through 2030 and % CAGR
  • TABLE 36: World Historic Review for Hospitals by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 37: World 15-Year Perspective for Hospitals by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2015, 2025 & 2030
  • TABLE 38: World Recent Past, Current & Future Analysis for Clinical Laboratories by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2024 through 2030 and % CAGR
  • TABLE 39: World Historic Review for Clinical Laboratories by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 40: World 15-Year Perspective for Clinical Laboratories by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2015, 2025 & 2030
  • TABLE 41: World Recent Past, Current & Future Analysis for Academic & Research Institutes by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2024 through 2030 and % CAGR
  • TABLE 42: World Historic Review for Academic & Research Institutes by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 43: World 15-Year Perspective for Academic & Research Institutes by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2015, 2025 & 2030
  • TABLE 44: World Recent Past, Current & Future Analysis for Other End-Uses by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2024 through 2030 and % CAGR
  • TABLE 45: World Historic Review for Other End-Uses by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 46: World 15-Year Perspective for Other End-Uses by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2015, 2025 & 2030
  • TABLE 47: World Recent Past, Current & Future Analysis for Enzyme-linked Immunosorbent Assay by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2024 through 2030 and % CAGR
  • TABLE 48: World Historic Review for Enzyme-linked Immunosorbent Assay by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 49: World 15-Year Perspective for Enzyme-linked Immunosorbent Assay by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2015, 2025 & 2030
  • TABLE 50: World Recent Past, Current & Future Analysis for Chemiluminescence Immunoassay by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2024 through 2030 and % CAGR
  • TABLE 51: World Historic Review for Chemiluminescence Immunoassay by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 52: World 15-Year Perspective for Chemiluminescence Immunoassay by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2015, 2025 & 2030
  • TABLE 53: World Recent Past, Current & Future Analysis for Fluorescent Immunoassay by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2024 through 2030 and % CAGR
  • TABLE 54: World Historic Review for Fluorescent Immunoassay by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 55: World 15-Year Perspective for Fluorescent Immunoassay by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2015, 2025 & 2030
  • TABLE 56: World Recent Past, Current & Future Analysis for Radioimmunoassay by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2024 through 2030 and % CAGR
  • TABLE 57: World Historic Review for Radioimmunoassay by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 58: World 15-Year Perspective for Radioimmunoassay by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2015, 2025 & 2030
  • TABLE 59: World Recent Past, Current & Future Analysis for Other Technologies by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2024 through 2030 and % CAGR
  • TABLE 60: World Historic Review for Other Technologies by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 61: World 15-Year Perspective for Other Technologies by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2015, 2025 & 2030

III. MARKET ANALYSIS

• UNITED STATES
  • Immunodiagnostics Market Presence - Strong/Active/Niche/Trivial - Key Competitors in the United States for 2025 (E)
  • TABLE 62: USA Recent Past, Current & Future Analysis for Immunodiagnostics by Product Type - Reagents, Instruments and Software & Services - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 63: USA Historic Review for Immunodiagnostics by Product Type - Reagents, Instruments and Software & Services Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 64: USA 15-Year Perspective for Immunodiagnostics by Product Type - Percentage Breakdown of Value Sales for Reagents, Instruments and Software & Services for the Years 2015, 2025 & 2030
  • TABLE 65: USA Recent Past, Current & Future Analysis for Immunodiagnostics by Application - Oncology & Endocrinology, Bone & Mineral Diseases, Autoimmune Disorders, Cardiac Biomarkers, Drug Monitoring, Other Applications and Infectious Diseases - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 66: USA Historic Review for Immunodiagnostics by Application - Oncology & Endocrinology, Bone & Mineral Diseases, Autoimmune Disorders, Cardiac Biomarkers, Drug Monitoring, Other Applications and Infectious Diseases Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 67: USA 15-Year Perspective for Immunodiagnostics by Application - Percentage Breakdown of Value Sales for Oncology & Endocrinology, Bone & Mineral Diseases, Autoimmune Disorders, Cardiac Biomarkers, Drug Monitoring, Other Applications and Infectious Diseases for the Years 2015, 2025 & 2030
  • TABLE 68: USA Recent Past, Current & Future Analysis for Immunodiagnostics by End-Use - Hospitals, Clinical Laboratories, Academic & Research Institutes and Other End-Uses - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 69: USA Historic Review for Immunodiagnostics by End-Use - Hospitals, Clinical Laboratories, Academic & Research Institutes and Other End-Uses Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 70: USA 15-Year Perspective for Immunodiagnostics by End-Use - Percentage Breakdown of Value Sales for Hospitals, Clinical Laboratories, Academic & Research Institutes and Other End-Uses for the Years 2015, 2025 & 2030
  • TABLE 71: USA Recent Past, Current & Future Analysis for Immunodiagnostics by Technology - Enzyme-linked Immunosorbent Assay, Chemiluminescence Immunoassay, Fluorescent Immunoassay, Radioimmunoassay and Other Technologies - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 72: USA Historic Review for Immunodiagnostics by Technology - Enzyme-linked Immunosorbent Assay, Chemiluminescence Immunoassay, Fluorescent Immunoassay, Radioimmunoassay and Other Technologies Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 73: USA 15-Year Perspective for Immunodiagnostics by Technology - Percentage Breakdown of Value Sales for Enzyme-linked Immunosorbent Assay, Chemiluminescence Immunoassay, Fluorescent Immunoassay, Radioimmunoassay and Other Technologies for the Years 2015, 2025 & 2030
• CANADA
  • TABLE 74: Canada Recent Past, Current & Future Analysis for Immunodiagnostics by Product Type - Reagents, Instruments and Software & Services - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 75: Canada Historic Review for Immunodiagnostics by Product Type - Reagents, Instruments and Software & Services Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 76: Canada 15-Year Perspective for Immunodiagnostics by Product Type - Percentage Breakdown of Value Sales for Reagents, Instruments and Software & Services for the Years 2015, 2025 & 2030
  • TABLE 77: Canada Recent Past, Current & Future Analysis for Immunodiagnostics by Application - Oncology & Endocrinology, Bone & Mineral Diseases, Autoimmune Disorders, Cardiac Biomarkers, Drug Monitoring, Other Applications and Infectious Diseases - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 78: Canada Historic Review for Immunodiagnostics by Application - Oncology & Endocrinology, Bone & Mineral Diseases, Autoimmune Disorders, Cardiac Biomarkers, Drug Monitoring, Other Applications and Infectious Diseases Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 79: Canada 15-Year Perspective for Immunodiagnostics by Application - Percentage Breakdown of Value Sales for Oncology & Endocrinology, Bone & Mineral Diseases, Autoimmune Disorders, Cardiac Biomarkers, Drug Monitoring, Other Applications and Infectious Diseases for the Years 2015, 2025 & 2030
  • TABLE 80: Canada Recent Past, Current & Future Analysis for Immunodiagnostics by End-Use - Hospitals, Clinical Laboratories, Academic & Research Institutes and Other End-Uses - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 81: Canada Historic Review for Immunodiagnostics by End-Use - Hospitals, Clinical Laboratories, Academic & Research Institutes and Other End-Uses Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 82: Canada 15-Year Perspective for Immunodiagnostics by End-Use - Percentage Breakdown of Value Sales for Hospitals, Clinical Laboratories, Academic & Research Institutes and Other End-Uses for the Years 2015, 2025 & 2030
  • TABLE 83: Canada Recent Past, Current & Future Analysis for Immunodiagnostics by Technology - Enzyme-linked Immunosorbent Assay, Chemiluminescence Immunoassay, Fluorescent Immunoassay, Radioimmunoassay and Other Technologies - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 84: Canada Historic Review for Immunodiagnostics by Technology - Enzyme-linked Immunosorbent Assay, Chemiluminescence Immunoassay, Fluorescent Immunoassay, Radioimmunoassay and Other Technologies Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 85: Canada 15-Year Perspective for Immunodiagnostics by Technology - Percentage Breakdown of Value Sales for Enzyme-linked Immunosorbent Assay, Chemiluminescence Immunoassay, Fluorescent Immunoassay, Radioimmunoassay and Other Technologies for the Years 2015, 2025 & 2030
• JAPAN
  • Immunodiagnostics Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Japan for 2025 (E)
  • TABLE 86: Japan Recent Past, Current & Future Analysis for Immunodiagnostics by Product Type - Reagents, Instruments and Software & Services - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 87: Japan Historic Review for Immunodiagnostics by Product Type - Reagents, Instruments and Software & Services Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 88: Japan 15-Year Perspective for Immunodiagnostics by Product Type - Percentage Breakdown of Value Sales for Reagents, Instruments and Software & Services for the Years 2015, 2025 & 2030
  • TABLE 89: Japan Recent Past, Current & Future Analysis for Immunodiagnostics by Application - Oncology & Endocrinology, Bone & Mineral Diseases, Autoimmune Disorders, Cardiac Biomarkers, Drug Monitoring, Other Applications and Infectious Diseases - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 90: Japan Historic Review for Immunodiagnostics by Application - Oncology & Endocrinology, Bone & Mineral Diseases, Autoimmune Disorders, Cardiac Biomarkers, Drug Monitoring, Other Applications and Infectious Diseases Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 91: Japan 15-Year Perspective for Immunodiagnostics by Application - Percentage Breakdown of Value Sales for Oncology & Endocrinology, Bone & Mineral Diseases, Autoimmune Disorders, Cardiac Biomarkers, Drug Monitoring, Other Applications and Infectious Diseases for the Years 2015, 2025 & 2030
  • TABLE 92: Japan Recent Past, Current & Future Analysis for Immunodiagnostics by End-Use - Hospitals, Clinical Laboratories, Academic & Research Institutes and Other End-Uses - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 93: Japan Historic Review for Immunodiagnostics by End-Use - Hospitals, Clinical Laboratories, Academic & Research Institutes and Other End-Uses Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 94: Japan 15-Year Perspective for Immunodiagnostics by End-Use - Percentage Breakdown of Value Sales for Hospitals, Clinical Laboratories, Academic & Research Institutes and Other End-Uses for the Years 2015, 2025 & 2030
  • TABLE 95: Japan Recent Past, Current & Future Analysis for Immunodiagnostics by Technology - Enzyme-linked Immunosorbent Assay, Chemiluminescence Immunoassay, Fluorescent Immunoassay, Radioimmunoassay and Other Technologies - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 96: Japan Historic Review for Immunodiagnostics by Technology - Enzyme-linked Immunosorbent Assay, Chemiluminescence Immunoassay, Fluorescent Immunoassay, Radioimmunoassay and Other Technologies Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 97: Japan 15-Year Perspective for Immunodiagnostics by Technology - Percentage Breakdown of Value Sales for Enzyme-linked Immunosorbent Assay, Chemiluminescence Immunoassay, Fluorescent Immunoassay, Radioimmunoassay and Other Technologies for the Years 2015, 2025 & 2030
• CHINA
  • Immunodiagnostics Market Presence - Strong/Active/Niche/Trivial - Key Competitors in China for 2025 (E)
  • TABLE 98: China Recent Past, Current & Future Analysis for Immunodiagnostics by Product Type - Reagents, Instruments and Software & Services - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 99: China Historic Review for Immunodiagnostics by Product Type - Reagents, Instruments and Software & Services Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 100: China 15-Year Perspective for Immunodiagnostics by Product Type - Percentage Breakdown of Value Sales for Reagents, Instruments and Software & Services for the Years 2015, 2025 & 2030
  • TABLE 101: China Recent Past, Current & Future Analysis for Immunodiagnostics by Application - Oncology & Endocrinology, Bone & Mineral Diseases, Autoimmune Disorders, Cardiac Biomarkers, Drug Monitoring, Other Applications and Infectious Diseases - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 102: China Historic Review for Immunodiagnostics by Application - Oncology & Endocrinology, Bone & Mineral Diseases, Autoimmune Disorders, Cardiac Biomarkers, Drug Monitoring, Other Applications and Infectious Diseases Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 103: China 15-Year Perspective for Immunodiagnostics by Application - Percentage Breakdown of Value Sales for Oncology & Endocrinology, Bone & Mineral Diseases, Autoimmune Disorders, Cardiac Biomarkers, Drug Monitoring, Other Applications and Infectious Diseases for the Years 2015, 2025 & 2030
  • TABLE 104: China Recent Past, Current & Future Analysis for Immunodiagnostics by End-Use - Hospitals, Clinical Laboratories, Academic & Research Institutes and Other End-Uses - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 105: China Historic Review for Immunodiagnostics by End-Use - Hospitals, Clinical Laboratories, Academic & Research Institutes and Other End-Uses Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 106: China 15-Year Perspective for Immunodiagnostics by End-Use - Percentage Breakdown of Value Sales for Hospitals, Clinical Laboratories, Academic & Research Institutes and Other End-Uses for the Years 2015, 2025 & 2030
  • TABLE 107: China Recent Past, Current & Future Analysis for Immunodiagnostics by Technology - Enzyme-linked Immunosorbent Assay, Chemiluminescence Immunoassay, Fluorescent Immunoassay, Radioimmunoassay and Other Technologies - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 108: China Historic Review for Immunodiagnostics by Technology - Enzyme-linked Immunosorbent Assay, Chemiluminescence Immunoassay, Fluorescent Immunoassay, Radioimmunoassay and Other Technologies Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 109: China 15-Year Perspective for Immunodiagnostics by Technology - Percentage Breakdown of Value Sales for Enzyme-linked Immunosorbent Assay, Chemiluminescence Immunoassay, Fluorescent Immunoassay, Radioimmunoassay and Other Technologies for the Years 2015, 2025 & 2030
• EUROPE
  • Immunodiagnostics Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Europe for 2025 (E)
  • TABLE 110: Europe Recent Past, Current & Future Analysis for Immunodiagnostics by Geographic Region - France, Germany, Italy, UK, Spain, Russia and Rest of Europe Markets - Independent Analysis of Annual Sales in US$ Million for Years 2024 through 2030 and % CAGR
  • TABLE 111: Europe Historic Review for Immunodiagnostics by Geographic Region - France, Germany, Italy, UK, Spain, Russia and Rest of Europe Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 112: Europe 15-Year Perspective for Immunodiagnostics by Geographic Region - Percentage Breakdown of Value Sales for France, Germany, Italy, UK, Spain, Russia and Rest of Europe Markets for Years 2015, 2025 & 2030
  • TABLE 113: Europe Recent Past, Current & Future Analysis for Immunodiagnostics by Product Type - Reagents, Instruments and Software & Services - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 114: Europe Historic Review for Immunodiagnostics by Product Type - Reagents, Instruments and Software & Services Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 115: Europe 15-Year Perspective for Immunodiagnostics by Product Type - Percentage Breakdown of Value Sales for Reagents, Instruments and Software & Services for the Years 2015, 2025 & 2030
  • TABLE 116: Europe Recent Past, Current & Future Analysis for Immunodiagnostics by Application - Oncology & Endocrinology, Bone & Mineral Diseases, Autoimmune Disorders, Cardiac Biomarkers, Drug Monitoring, Other Applications and Infectious Diseases - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 117: Europe Historic Review for Immunodiagnostics by Application - Oncology & Endocrinology, Bone & Mineral Diseases, Autoimmune Disorders, Cardiac Biomarkers, Drug Monitoring, Other Applications and Infectious Diseases Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 118: Europe 15-Year Perspective for Immunodiagnostics by Application - Percentage Breakdown of Value Sales for Oncology & Endocrinology, Bone & Mineral Diseases, Autoimmune Disorders, Cardiac Biomarkers, Drug Monitoring, Other Applications and Infectious Diseases for the Years 2015, 2025 & 2030
  • TABLE 119: Europe Recent Past, Current & Future Analysis for Immunodiagnostics by End-Use - Hospitals, Clinical Laboratories, Academic & Research Institutes and Other End-Uses - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 120: Europe Historic Review for Immunodiagnostics by End-Use - Hospitals, Clinical Laboratories, Academic & Research Institutes and Other End-Uses Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 121: Europe 15-Year Perspective for Immunodiagnostics by End-Use - Percentage Breakdown of Value Sales for Hospitals, Clinical Laboratories, Academic & Research Institutes and Other End-Uses for the Years 2015, 2025 & 2030
  • TABLE 122: Europe Recent Past, Current & Future Analysis for Immunodiagnostics by Technology - Enzyme-linked Immunosorbent Assay, Chemiluminescence Immunoassay, Fluorescent Immunoassay, Radioimmunoassay and Other Technologies - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 123: Europe Historic Review for Immunodiagnostics by Technology - Enzyme-linked Immunosorbent Assay, Chemiluminescence Immunoassay, Fluorescent Immunoassay, Radioimmunoassay and Other Technologies Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 124: Europe 15-Year Perspective for Immunodiagnostics by Technology - Percentage Breakdown of Value Sales for Enzyme-linked Immunosorbent Assay, Chemiluminescence Immunoassay, Fluorescent Immunoassay, Radioimmunoassay and Other Technologies for the Years 2015, 2025 & 2030
• FRANCE
  • Immunodiagnostics Market Presence - Strong/Active/Niche/Trivial - Key Competitors in France for 2025 (E)
  • TABLE 125: France Recent Past, Current & Future Analysis for Immunodiagnostics by Product Type - Reagents, Instruments and Software & Services - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 126: France Historic Review for Immunodiagnostics by Product Type - Reagents, Instruments and Software & Services Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 127: France 15-Year Perspective for Immunodiagnostics by Product Type - Percentage Breakdown of Value Sales for Reagents, Instruments and Software & Services for the Years 2015, 2025 & 2030
  • TABLE 128: France Recent Past, Current & Future Analysis for Immunodiagnostics by Application - Oncology & Endocrinology, Bone & Mineral Diseases, Autoimmune Disorders, Cardiac Biomarkers, Drug Monitoring, Other Applications and Infectious Diseases - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 129: France Historic Review for Immunodiagnostics by Application - Oncology & Endocrinology, Bone & Mineral Diseases, Autoimmune Disorders, Cardiac Biomarkers, Drug Monitoring, Other Applications and Infectious Diseases Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 130: France 15-Year Perspective for Immunodiagnostics by Application - Percentage Breakdown of Value Sales for Oncology & Endocrinology, Bone & Mineral Diseases, Autoimmune Disorders, Cardiac Biomarkers, Drug Monitoring, Other Applications and Infectious Diseases for the Years 2015, 2025 & 2030
  • TABLE 131: France Recent Past, Current & Future Analysis for Immunodiagnostics by End-Use - Hospitals, Clinical Laboratories, Academic & Research Institutes and Other End-Uses - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 132: France Historic Review for Immunodiagnostics by End-Use - Hospitals, Clinical Laboratories, Academic & Research Institutes and Other End-Uses Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 133: France 15-Year Perspective for Immunodiagnostics by End-Use - Percentage Breakdown of Value Sales for Hospitals, Clinical Laboratories, Academic & Research Institutes and Other End-Uses for the Years 2015, 2025 & 2030
  • TABLE 134: France Recent Past, Current & Future Analysis for Immunodiagnostics by Technology - Enzyme-linked Immunosorbent Assay, Chemiluminescence Immunoassay, Fluorescent Immunoassay, Radioimmunoassay and Other Technologies - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 135: France Historic Review for Immunodiagnostics by Technology - Enzyme-linked Immunosorbent Assay, Chemiluminescence Immunoassay, Fluorescent Immunoassay, Radioimmunoassay and Other Technologies Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 136: France 15-Year Perspective for Immunodiagnostics by Technology - Percentage Breakdown of Value Sales for Enzyme-linked Immunosorbent Assay, Chemiluminescence Immunoassay, Fluorescent Immunoassay, Radioimmunoassay and Other Technologies for the Years 2015, 2025 & 2030
• GERMANY
  • Immunodiagnostics Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Germany for 2025 (E)
  • TABLE 137: Germany Recent Past, Current & Future Analysis for Immunodiagnostics by Product Type - Reagents, Instruments and Software & Services - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 138: Germany Historic Review for Immunodiagnostics by Product Type - Reagents, Instruments and Software & Services Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 139: Germany 15-Year Perspective for Immunodiagnostics by Product Type - Percentage Breakdown of Value Sales for Reagents, Instruments and Software & Services for the Years 2015, 2025 & 2030
  • TABLE 140: Germany Recent Past, Current & Future Analysis for Immunodiagnostics by Application - Oncology & Endocrinology, Bone & Mineral Diseases, Autoimmune Disorders, Cardiac Biomarkers, Drug Monitoring, Other Applications and Infectious Diseases - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 141: Germany Historic Review for Immunodiagnostics by Application - Oncology & Endocrinology, Bone & Mineral Diseases, Autoimmune Disorders, Cardiac Biomarkers, Drug Monitoring, Other Applications and Infectious Diseases Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 142: Germany 15-Year Perspective for Immunodiagnostics by Application - Percentage Breakdown of Value Sales for Oncology & Endocrinology, Bone & Mineral Diseases, Autoimmune Disorders, Cardiac Biomarkers, Drug Monitoring, Other Applications and Infectious Diseases for the Years 2015, 2025 & 2030
  • TABLE 143: Germany Recent Past, Current & Future Analysis for Immunodiagnostics by End-Use - Hospitals, Clinical Laboratories, Academic & Research Institutes and Other End-Uses - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 144: Germany Historic Review for Immunodiagnostics by End-Use - Hospitals, Clinical Laboratories, Academic & Research Institutes and Other End-Uses Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 145: Germany 15-Year Perspective for Immunodiagnostics by End-Use - Percentage Breakdown of Value Sales for Hospitals, Clinical Laboratories, Academic & Research Institutes and Other End-Uses for the Years 2015, 2025 & 2030
  • TABLE 146: Germany Recent Past, Current & Future Analysis for Immunodiagnostics by Technology - Enzyme-linked Immunosorbent Assay, Chemiluminescence Immunoassay, Fluorescent Immunoassay, Radioimmunoassay and Other Technologies - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 147: Germany Historic Review for Immunodiagnostics by Technology - Enzyme-linked Immunosorbent Assay, Chemiluminescence Immunoassay, Fluorescent Immunoassay, Radioimmunoassay and Other Technologies Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 148: Germany 15-Year Perspective for Immunodiagnostics by Technology - Percentage Breakdown of Value Sales for Enzyme-linked Immunosorbent Assay, Chemiluminescence Immunoassay, Fluorescent Immunoassay, Radioimmunoassay and Other Technologies for the Years 2015, 2025 & 2030
• ITALY
  • TABLE 149: Italy Recent Past, Current & Future Analysis for Immunodiagnostics by Product Type - Reagents, Instruments and Software & Services - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 150: Italy Historic Review for Immunodiagnostics by Product Type - Reagents, Instruments and Software & Services Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 151: Italy 15-Year Perspective for Immunodiagnostics by Product Type - Percentage Breakdown of Value Sales for Reagents, Instruments and Software & Services for the Years 2015, 2025 & 2030
  • TABLE 152: Italy Recent Past, Current & Future Analysis for Immunodiagnostics by Application - Oncology & Endocrinology, Bone & Mineral Diseases, Autoimmune Disorders, Cardiac Biomarkers, Drug Monitoring, Other Applications and Infectious Diseases - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 153: Italy Historic Review for Immunodiagnostics by Application - Oncology & Endocrinology, Bone & Mineral Diseases, Autoimmune Disorders, Cardiac Biomarkers, Drug Monitoring, Other Applications and Infectious Diseases Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 154: Italy 15-Year Perspective for Immunodiagnostics by Application - Percentage Breakdown of Value Sales for Oncology & Endocrinology, Bone & Mineral Diseases, Autoimmune Disorders, Cardiac Biomarkers, Drug Monitoring, Other Applications and Infectious Diseases for the Years 2015, 2025 & 2030
  • TABLE 155: Italy Recent Past, Current & Future Analysis for Immunodiagnostics by End-Use - Hospitals, Clinical Laboratories, Academic & Research Institutes and Other End-Uses - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 156: Italy Historic Review for Immunodiagnostics by End-Use - Hospitals, Clinical Laboratories, Academic & Research Institutes and Other End-Uses Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 157: Italy 15-Year Perspective for Immunodiagnostics by End-Use - Percentage Breakdown of Value Sales for Hospitals, Clinical Laboratories, Academic & Research Institutes and Other End-Uses for the Years 2015, 2025 & 2030
  • TABLE 158: Italy Recent Past, Current & Future Analysis for Immunodiagnostics by Technology - Enzyme-linked Immunosorbent Assay, Chemiluminescence Immunoassay, Fluorescent Immunoassay, Radioimmunoassay and Other Technologies - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 159: Italy Historic Review for Immunodiagnostics by Technology - Enzyme-linked Immunosorbent Assay, Chemiluminescence Immunoassay, Fluorescent Immunoassay, Radioimmunoassay and Other Technologies Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 160: Italy 15-Year Perspective for Immunodiagnostics by Technology - Percentage Breakdown of Value Sales for Enzyme-linked Immunosorbent Assay, Chemiluminescence Immunoassay, Fluorescent Immunoassay, Radioimmunoassay and Other Technologies for the Years 2015, 2025 & 2030
• UNITED KINGDOM
  • Immunodiagnostics Market Presence - Strong/Active/Niche/Trivial - Key Competitors in the United Kingdom for 2025 (E)
  • TABLE 161: UK Recent Past, Current & Future Analysis for Immunodiagnostics by Product Type - Reagents, Instruments and Software & Services - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 162: UK Historic Review for Immunodiagnostics by Product Type - Reagents, Instruments and Software & Services Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 163: UK 15-Year Perspective for Immunodiagnostics by Product Type - Percentage Breakdown of Value Sales for Reagents, Instruments and Software & Services for the Years 2015, 2025 & 2030
  • TABLE 164: UK Recent Past, Current & Future Analysis for Immunodiagnostics by Application - Oncology & Endocrinology, Bone & Mineral Diseases, Autoimmune Disorders, Cardiac Biomarkers, Drug Monitoring, Other Applications and Infectious Diseases - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 165: UK Historic Review for Immunodiagnostics by Application - Oncology & Endocrinology, Bone & Mineral Diseases, Autoimmune Disorders, Cardiac Biomarkers, Drug Monitoring, Other Applications and Infectious Diseases Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 166: UK 15-Year Perspective for Immunodiagnostics by Application - Percentage Breakdown of Value Sales for Oncology & Endocrinology, Bone & Mineral Diseases, Autoimmune Disorders, Cardiac Biomarkers, Drug Monitoring, Other Applications and Infectious Diseases for the Years 2015, 2025 & 2030
  • TABLE 167: UK Recent Past, Current & Future Analysis for Immunodiagnostics by End-Use - Hospitals, Clinical Laboratories, Academic & Research Institutes and Other End-Uses - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 168: UK Historic Review for Immunodiagnostics by End-Use - Hospitals, Clinical Laboratories, Academic & Research Institutes and Other End-Uses Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 169: UK 15-Year Perspective for Immunodiagnostics by End-Use - Percentage Breakdown of Value Sales for Hospitals, Clinical Laboratories, Academic & Research Institutes and Other End-Uses for the Years 2015, 2025 & 2030
  • TABLE 170: UK Recent Past, Current & Future Analysis for Immunodiagnostics by Technology - Enzyme-linked Immunosorbent Assay, Chemiluminescence Immunoassay, Fluorescent Immunoassay, Radioimmunoassay and Other Technologies - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 171: UK Historic Review for Immunodiagnostics by Technology - Enzyme-linked Immunosorbent Assay, Chemiluminescence Immunoassay, Fluorescent Immunoassay, Radioimmunoassay and Other Technologies Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 172: UK 15-Year Perspective for Immunodiagnostics by Technology - Percentage Breakdown of Value Sales for Enzyme-linked Immunosorbent Assay, Chemiluminescence Immunoassay, Fluorescent Immunoassay, Radioimmunoassay and Other Technologies for the Years 2015, 2025 & 2030
• SPAIN
  • TABLE 173: Spain Recent Past, Current & Future Analysis for Immunodiagnostics by Product Type - Reagents, Instruments and Software & Services - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 174: Spain Historic Review for Immunodiagnostics by Product Type - Reagents, Instruments and Software & Services Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 175: Spain 15-Year Perspective for Immunodiagnostics by Product Type - Percentage Breakdown of Value Sales for Reagents, Instruments and Software & Services for the Years 2015, 2025 & 2030
  • TABLE 176: Spain Recent Past, Current & Future Analysis for Immunodiagnostics by Application - Oncology & Endocrinology, Bone & Mineral Diseases, Autoimmune Disorders, Cardiac Biomarkers, Drug Monitoring, Other Applications and Infectious Diseases - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 177: Spain Historic Review for Immunodiagnostics by Application - Oncology & Endocrinology, Bone & Mineral Diseases, Autoimmune Disorders, Cardiac Biomarkers, Drug Monitoring, Other Applications and Infectious Diseases Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 178: Spain 15-Year Perspective for Immunodiagnostics by Application - Percentage Breakdown of Value Sales for Oncology & Endocrinology, Bone & Mineral Diseases, Autoimmune Disorders, Cardiac Biomarkers, Drug Monitoring, Other Applications and Infectious Diseases for the Years 2015, 2025 & 2030
  • TABLE 179: Spain Recent Past, Current & Future Analysis for Immunodiagnostics by End-Use - Hospitals, Clinical Laboratories, Academic & Research Institutes and Other End-Uses - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 180: Spain Historic Review for Immunodiagnostics by End-Use - Hospitals, Clinical Laboratories, Academic & Research Institutes and Other End-Uses Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 181: Spain 15-Year Perspective for Immunodiagnostics by End-Use - Percentage Breakdown of Value Sales for Hospitals, Clinical Laboratories, Academic & Research Institutes and Other End-Uses for the Years 2015, 2025 & 2030
  • TABLE 182: Spain Recent Past, Current & Future Analysis for Immunodiagnostics by Technology - Enzyme-linked Immunosorbent Assay, Chemiluminescence Immunoassay, Fluorescent Immunoassay, Radioimmunoassay and Other Technologies - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 183: Spain Historic Review for Immunodiagnostics by Technology - Enzyme-linked Immunosorbent Assay, Chemiluminescence Immunoassay, Fluorescent Immunoassay, Radioimmunoassay and Other Technologies Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 184: Spain 15-Year Perspective for Immunodiagnostics by Technology - Percentage Breakdown of Value Sales for Enzyme-linked Immunosorbent Assay, Chemiluminescence Immunoassay, Fluorescent Immunoassay, Radioimmunoassay and Other Technologies for the Years 2015, 2025 & 2030
• RUSSIA
  • TABLE 185: Russia Recent Past, Current & Future Analysis for Immunodiagnostics by Product Type - Reagents, Instruments and Software & Services - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 186: Russia Historic Review for Immunodiagnostics by Product Type - Reagents, Instruments and Software & Services Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 187: Russia 15-Year Perspective for Immunodiagnostics by Product Type - Percentage Breakdown of Value Sales for Reagents, Instruments and Software & Services for the Years 2015, 2025 & 2030
  • TABLE 188: Russia Recent Past, Current & Future Analysis for Immunodiagnostics by Application - Oncology & Endocrinology, Bone & Mineral Diseases, Autoimmune Disorders, Cardiac Biomarkers, Drug Monitoring, Other Applications and Infectious Diseases - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 189: Russia Historic Review for Immunodiagnostics by Application - Oncology & Endocrinology, Bone & Mineral Diseases, Autoimmune Disorders, Cardiac Biomarkers, Drug Monitoring, Other Applications and Infectious Diseases Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 190: Russia 15-Year Perspective for Immunodiagnostics by Application - Percentage Breakdown of Value Sales for Oncology & Endocrinology, Bone & Mineral Diseases, Autoimmune Disorders, Cardiac Biomarkers, Drug Monitoring, Other Applications and Infectious Diseases for the Years 2015, 2025 & 2030
  • TABLE 191: Russia Recent Past, Current & Future Analysis for Immunodiagnostics by End-Use - Hospitals, Clinical Laboratories, Academic & Research Institutes and Other End-Uses - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 192: Russia Historic Review for Immunodiagnostics by End-Use - Hospitals, Clinical Laboratories, Academic & Research Institutes and Other End-Uses Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 193: Russia 15-Year Perspective for Immunodiagnostics by End-Use - Percentage Breakdown of Value Sales for Hospitals, Clinical Laboratories, Academic & Research Institutes and Other End-Uses for the Years 2015, 2025 & 2030
  • TABLE 194: Russia Recent Past, Current & Future Analysis for Immunodiagnostics by Technology - Enzyme-linked Immunosorbent Assay, Chemiluminescence Immunoassay, Fluorescent Immunoassay, Radioimmunoassay and Other Technologies - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 195: Russia Historic Review for Immunodiagnostics by Technology - Enzyme-linked Immunosorbent Assay, Chemiluminescence Immunoassay, Fluorescent Immunoassay, Radioimmunoassay and Other Technologies Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 196: Russia 15-Year Perspective for Immunodiagnostics by Technology - Percentage Breakdown of Value Sales for Enzyme-linked Immunosorbent Assay, Chemiluminescence Immunoassay, Fluorescent Immunoassay, Radioimmunoassay and Other Technologies for the Years 2015, 2025 & 2030
• REST OF EUROPE
  • TABLE 197: Rest of Europe Recent Past, Current & Future Analysis for Immunodiagnostics by Product Type - Reagents, Instruments and Software & Services - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 198: Rest of Europe Historic Review for Immunodiagnostics by Product Type - Reagents, Instruments and Software & Services Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 199: Rest of Europe 15-Year Perspective for Immunodiagnostics by Product Type - Percentage Breakdown of Value Sales for Reagents, Instruments and Software & Services for the Years 2015, 2025 & 2030
  • TABLE 200: Rest of Europe Recent Past, Current & Future Analysis for Immunodiagnostics by Application - Oncology & Endocrinology, Bone & Mineral Diseases, Autoimmune Disorders, Cardiac Biomarkers, Drug Monitoring, Other Applications and Infectious Diseases - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 201: Rest of Europe Historic Review for Immunodiagnostics by Application - Oncology & Endocrinology, Bone & Mineral Diseases, Autoimmune Disorders, Cardiac Biomarkers, Drug Monitoring, Other Applications and Infectious Diseases Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 202: Rest of Europe 15-Year Perspective for Immunodiagnostics by Application - Percentage Breakdown of Value Sales for Oncology & Endocrinology, Bone & Mineral Diseases, Autoimmune Disorders, Cardiac Biomarkers, Drug Monitoring, Other Applications and Infectious Diseases for the Years 2015, 2025 & 2030
  • TABLE 203: Rest of Europe Recent Past, Current & Future Analysis for Immunodiagnostics by End-Use - Hospitals, Clinical Laboratories, Academic & Research Institutes and Other End-Uses - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 204: Rest of Europe Historic Review for Immunodiagnostics by End-Use - Hospitals, Clinical Laboratories, Academic & Research Institutes and Other End-Uses Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 205: Rest of Europe 15-Year Perspective for Immunodiagnostics by End-Use - Percentage Breakdown of Value Sales for Hospitals, Clinical Laboratories, Academic & Research Institutes and Other End-Uses for the Years 2015, 2025 & 2030
  • TABLE 206: Rest of Europe Recent Past, Current & Future Analysis for Immunodiagnostics by Technology - Enzyme-linked Immunosorbent Assay, Chemiluminescence Immunoassay, Fluorescent Immunoassay, Radioimmunoassay and Other Technologies - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 207: Rest of Europe Historic Review for Immunodiagnostics by Technology - Enzyme-linked Immunosorbent Assay, Chemiluminescence Immunoassay, Fluorescent Immunoassay, Radioimmunoassay and Other Technologies Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 208: Rest of Europe 15-Year Perspective for Immunodiagnostics by Technology - Percentage Breakdown of Value Sales for Enzyme-linked Immunosorbent Assay, Chemiluminescence Immunoassay, Fluorescent Immunoassay, Radioimmunoassay and Other Technologies for the Years 2015, 2025 & 2030
• ASIA-PACIFIC
  • Immunodiagnostics Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Asia-Pacific for 2025 (E)
  • TABLE 209: Asia-Pacific Recent Past, Current & Future Analysis for Immunodiagnostics by Geographic Region - Australia, India, South Korea and Rest of Asia-Pacific Markets - Independent Analysis of Annual Sales in US$ Million for Years 2024 through 2030 and % CAGR
  • TABLE 210: Asia-Pacific Historic Review for Immunodiagnostics by Geographic Region - Australia, India, South Korea and Rest of Asia-Pacific Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 211: Asia-Pacific 15-Year Perspective for Immunodiagnostics by Geographic Region - Percentage Breakdown of Value Sales for Australia, India, South Korea and Rest of Asia-Pacific Markets for Years 2015, 2025 & 2030
  • TABLE 212: Asia-Pacific Recent Past, Current & Future Analysis for Immunodiagnostics by Product Type - Reagents, Instruments and Software & Services - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 213: Asia-Pacific Historic Review for Immunodiagnostics by Product Type - Reagents, Instruments and Software & Services Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 214: Asia-Pacific 15-Year Perspective for Immunodiagnostics by Product Type - Percentage Breakdown of Value Sales for Reagents, Instruments and Software & Services for the Years 2015, 2025 & 2030
  • TABLE 215: Asia-Pacific Recent Past, Current & Future Analysis for Immunodiagnostics by Application - Oncology & Endocrinology, Bone & Mineral Diseases, Autoimmune Disorders, Cardiac Biomarkers, Drug Monitoring, Other Applications and Infectious Diseases - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 216: Asia-Pacific Historic Review for Immunodiagnostics by Application - Oncology & Endocrinology, Bone & Mineral Diseases, Autoimmune Disorders, Cardiac Biomarkers, Drug Monitoring, Other Applications and Infectious Diseases Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 217: Asia-Pacific 15-Year Perspective for Immunodiagnostics by Application - Percentage Breakdown of Value Sales for Oncology & Endocrinology, Bone & Mineral Diseases, Autoimmune Disorders, Cardiac Biomarkers, Drug Monitoring, Other Applications and Infectious Diseases for the Years 2015, 2025 & 2030
  • TABLE 218: Asia-Pacific Recent Past, Current & Future Analysis for Immunodiagnostics by End-Use - Hospitals, Clinical Laboratories, Academic & Research Institutes and Other End-Uses - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 219: Asia-Pacific Historic Review for Immunodiagnostics by End-Use - Hospitals, Clinical Laboratories, Academic & Research Institutes and Other End-Uses Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 220: Asia-Pacific 15-Year Perspective for Immunodiagnostics by End-Use - Percentage Breakdown of Value Sales for Hospitals, Clinical Laboratories, Academic & Research Institutes and Other End-Uses for the Years 2015, 2025 & 2030
  • TABLE 221: Asia-Pacific Recent Past, Current & Future Analysis for Immunodiagnostics by Technology - Enzyme-linked Immunosorbent Assay, Chemiluminescence Immunoassay, Fluorescent Immunoassay, Radioimmunoassay and Other Technologies - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 222: Asia-Pacific Historic Review for Immunodiagnostics by Technology - Enzyme-linked Immunosorbent Assay, Chemiluminescence Immunoassay, Fluorescent Immunoassay, Radioimmunoassay and Other Technologies Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 223: Asia-Pacific 15-Year Perspective for Immunodiagnostics by Technology - Percentage Breakdown of Value Sales for Enzyme-linked Immunosorbent Assay, Chemiluminescence Immunoassay, Fluorescent Immunoassay, Radioimmunoassay and Other Technologies for the Years 2015, 2025 & 2030
• AUSTRALIA
  • Immunodiagnostics Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Australia for 2025 (E)
  • TABLE 224: Australia Recent Past, Current & Future Analysis for Immunodiagnostics by Product Type - Reagents, Instruments and Software & Services - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 225: Australia Historic Review for Immunodiagnostics by Product Type - Reagents, Instruments and Software & Services Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 226: Australia 15-Year Perspective for Immunodiagnostics by Product Type - Percentage Breakdown of Value Sales for Reagents, Instruments and Software & Services for the Years 2015, 2025 & 2030
  • TABLE 227: Australia Recent Past, Current & Future Analysis for Immunodiagnostics by Application - Oncology & Endocrinology, Bone & Mineral Diseases, Autoimmune Disorders, Cardiac Biomarkers, Drug Monitoring, Other Applications and Infectious Diseases - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 228: Australia Historic Review for Immunodiagnostics by Application - Oncology & Endocrinology, Bone & Mineral Diseases, Autoimmune Disorders, Cardiac Biomarkers, Drug Monitoring, Other Applications and Infectious Diseases Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 229: Australia 15-Year Perspective for Immunodiagnostics by Application - Percentage Breakdown of Value Sales for Oncology & Endocrinology, Bone & Mineral Diseases, Autoimmune Disorders, Cardiac Biomarkers, Drug Monitoring, Other Applications and Infectious Diseases for the Years 2015, 2025 & 2030
  • TABLE 230: Australia Recent Past, Current & Future Analysis for Immunodiagnostics by End-Use - Hospitals, Clinical Laboratories, Academic & Research Institutes and Other End-Uses - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 231: Australia Historic Review for Immunodiagnostics by End-Use - Hospitals, Clinical Laboratories, Academic & Research Institutes and Other End-Uses Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 232: Australia 15-Year Perspective for Immunodiagnostics by End-Use - Percentage Breakdown of Value Sales for Hospitals, Clinical Laboratories, Academic & Research Institutes and Other End-Uses for the Years 2015, 2025 & 2030
  • TABLE 233: Australia Recent Past, Current & Future Analysis for Immunodiagnostics by Technology - Enzyme-linked Immunosorbent Assay, Chemiluminescence Immunoassay, Fluorescent Immunoassay, Radioimmunoassay and Other Technologies - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 234: Australia Historic Review for Immunodiagnostics by Technology - Enzyme-linked Immunosorbent Assay, Chemiluminescence Immunoassay, Fluorescent Immunoassay, Radioimmunoassay and Other Technologies Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 235: Australia 15-Year Perspective for Immunodiagnostics by Technology - Percentage Breakdown of Value Sales for Enzyme-linked Immunosorbent Assay, Chemiluminescence Immunoassay, Fluorescent Immunoassay, Radioimmunoassay and Other Technologies for the Years 2015, 2025 & 2030
• INDIA
  • Immunodiagnostics Market Presence - Strong/Active/Niche/Trivial - Key Competitors in India for 2025 (E)
  • TABLE 236: India Recent Past, Current & Future Analysis for Immunodiagnostics by Product Type - Reagents, Instruments and Software & Services - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 237: India Historic Review for Immunodiagnostics by Product Type - Reagents, Instruments and Software & Services Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 238: India 15-Year Perspective for Immunodiagnostics by Product Type - Percentage Breakdown of Value Sales for Reagents, Instruments and Software & Services for the Years 2015, 2025 & 2030
  • TABLE 239: India Recent Past, Current & Future Analysis for Immunodiagnostics by Application - Oncology & Endocrinology, Bone & Mineral Diseases, Autoimmune Disorders, Cardiac Biomarkers, Drug Monitoring, Other Applications and Infectious Diseases - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 240: India Historic Review for Immunodiagnostics by Application - Oncology & Endocrinology, Bone & Mineral Diseases, Autoimmune Disorders, Cardiac Biomarkers, Drug Monitoring, Other Applications and Infectious Diseases Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 241: India 15-Year Perspective for Immunodiagnostics by Application - Percentage Breakdown of Value Sales for Oncology & Endocrinology, Bone & Mineral Diseases, Autoimmune Disorders, Cardiac Biomarkers, Drug Monitoring, Other Applications and Infectious Diseases for the Years 2015, 2025 & 2030
  • TABLE 242: India Recent Past, Current & Future Analysis for Immunodiagnostics by End-Use - Hospitals, Clinical Laboratories, Academic & Research Institutes and Other End-Uses - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 243: India Historic Review for Immunodiagnostics by End-Use - Hospitals, Clinical Laboratories, Academic & Research Institutes and Other End-Uses Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 244: India 15-Year Perspective for Immunodiagnostics by End-Use - Percentage Breakdown of Value Sales for Hospitals, Clinical Laboratories, Academic & Research Institutes and Other End-Uses for the Years 2015, 2025 & 2030
  • TABLE 245: India Recent Past, Current & Future Analysis for Immunodiagnostics by Technology - Enzyme-linked Immunosorbent Assay, Chemiluminescence Immunoassay, Fluorescent Immunoassay, Radioimmunoassay and Other Technologies - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 246: India Historic Review for Immunodiagnostics by Technology - Enzyme-linked Immunosorbent Assay, Chemiluminescence Immunoassay, Fluorescent Immunoassay, Radioimmunoassay and Other Technologies Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 247: India 15-Year Perspective for Immunodiagnostics by Technology - Percentage Breakdown of Value Sales for Enzyme-linked Immunosorbent Assay, Chemiluminescence Immunoassay, Fluorescent Immunoassay, Radioimmunoassay and Other Technologies for the Years 2015, 2025 & 2030
• SOUTH KOREA
  • TABLE 248: South Korea Recent Past, Current & Future Analysis for Immunodiagnostics by Product Type - Reagents, Instruments and Software & Services - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 249: South Korea Historic Review for Immunodiagnostics by Product Type - Reagents, Instruments and Software & Services Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 250: South Korea 15-Year Perspective for Immunodiagnostics by Product Type - Percentage Breakdown of Value Sales for Reagents, Instruments and Software & Services for the Years 2015, 2025 & 2030
  • TABLE 251: South Korea Recent Past, Current & Future Analysis for Immunodiagnostics by Application - Oncology & Endocrinology, Bone & Mineral Diseases, Autoimmune Disorders, Cardiac Biomarkers, Drug Monitoring, Other Applications and Infectious Diseases - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 252: South Korea Historic Review for Immunodiagnostics by Application - Oncology & Endocrinology, Bone & Mineral Diseases, Autoimmune Disorders, Cardiac Biomarkers, Drug Monitoring, Other Applications and Infectious Diseases Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 253: South Korea 15-Year Perspective for Immunodiagnostics by Application - Percentage Breakdown of Value Sales for Oncology & Endocrinology, Bone & Mineral Diseases, Autoimmune Disorders, Cardiac Biomarkers, Drug Monitoring, Other Applications and Infectious Diseases for the Years 2015, 2025 & 2030
  • TABLE 254: South Korea Recent Past, Current & Future Analysis for Immunodiagnostics by End-Use - Hospitals, Clinical Laboratories, Academic & Research Institutes and Other End-Uses - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 255: South Korea Historic Review for Immunodiagnostics by End-Use - Hospitals, Clinical Laboratories, Academic & Research Institutes and Other End-Uses Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 256: South Korea 15-Year Perspective for Immunodiagnostics by End-Use - Percentage Breakdown of Value Sales for Hospitals, Clinical Laboratories, Academic & Research Institutes and Other End-Uses for the Years 2015, 2025 & 2030
  • TABLE 257: South Korea Recent Past, Current & Future Analysis for Immunodiagnostics by Technology - Enzyme-linked Immunosorbent Assay, Chemiluminescence Immunoassay, Fluorescent Immunoassay, Radioimmunoassay and Other Technologies - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 258: South Korea Historic Review for Immunodiagnostics by Technology - Enzyme-linked Immunosorbent Assay, Chemiluminescence Immunoassay, Fluorescent Immunoassay, Radioimmunoassay and Other Technologies Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 259: South Korea 15-Year Perspective for Immunodiagnostics by Technology - Percentage Breakdown of Value Sales for Enzyme-linked Immunosorbent Assay, Chemiluminescence Immunoassay, Fluorescent Immunoassay, Radioimmunoassay and Other Technologies for the Years 2015, 2025 & 2030
• REST OF ASIA-PACIFIC
  • TABLE 260: Rest of Asia-Pacific Recent Past, Current & Future Analysis for Immunodiagnostics by Product Type - Reagents, Instruments and Software & Services - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 261: Rest of Asia-Pacific Historic Review for Immunodiagnostics by Product Type - Reagents, Instruments and Software & Services Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 262: Rest of Asia-Pacific 15-Year Perspective for Immunodiagnostics by Product Type - Percentage Breakdown of Value Sales for Reagents, Instruments and Software & Services for the Years 2015, 2025 & 2030
  • TABLE 263: Rest of Asia-Pacific Recent Past, Current & Future Analysis for Immunodiagnostics by Application - Oncology & Endocrinology, Bone & Mineral Diseases, Autoimmune Disorders, Cardiac Biomarkers, Drug Monitoring, Other Applications and Infectious Diseases - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 264: Rest of Asia-Pacific Historic Review for Immunodiagnostics by Application - Oncology & Endocrinology, Bone & Mineral Diseases, Autoimmune Disorders, Cardiac Biomarkers, Drug Monitoring, Other Applications and Infectious Diseases Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 265: Rest of Asia-Pacific 15-Year Perspective for Immunodiagnostics by Application - Percentage Breakdown of Value Sales for Oncology & Endocrinology, Bone & Mineral Diseases, Autoimmune Disorders, Cardiac Biomarkers, Drug Monitoring, Other Applications and Infectious Diseases for the Years 2015, 2025 & 2030
  • TABLE 266: Rest of Asia-Pacific Recent Past, Current & Future Analysis for Immunodiagnostics by End-Use - Hospitals, Clinical Laboratories, Academic & Research Institutes and Other End-Uses - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 267: Rest of Asia-Pacific Historic Review for Immunodiagnostics by End-Use - Hospitals, Clinical Laboratories, Academic & Research Institutes and Other End-Uses Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 268: Rest of Asia-Pacific 15-Year Perspective for Immunodiagnostics by End-Use - Percentage Breakdown of Value Sales for Hospitals, Clinical Laboratories, Academic & Research Institutes and Other End-Uses for the Years 2015, 2025 & 2030
  • TABLE 269: Rest of Asia-Pacific Recent Past, Current & Future Analysis for Immunodiagnostics by Technology - Enzyme-linked Immunosorbent Assay, Chemiluminescence Immunoassay, Fluorescent Immunoassay, Radioimmunoassay and Other Technologies - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 270: Rest of Asia-Pacific Historic Review for Immunodiagnostics by Technology - Enzyme-linked Immunosorbent Assay, Chemiluminescence Immunoassay, Fluorescent Immunoassay, Radioimmunoassay and Other Technologies Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 271: Rest of Asia-Pacific 15-Year Perspective for Immunodiagnostics by Technology - Percentage Breakdown of Value Sales for Enzyme-linked Immunosorbent Assay, Chemiluminescence Immunoassay, Fluorescent Immunoassay, Radioimmunoassay and Other Technologies for the Years 2015, 2025 & 2030
• LATIN AMERICA
  • Immunodiagnostics Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Latin America for 2025 (E)
  • TABLE 272: Latin America Recent Past, Current & Future Analysis for Immunodiagnostics by Geographic Region - Argentina, Brazil, Mexico and Rest of Latin America Markets - Independent Analysis of Annual Sales in US$ Million for Years 2024 through 2030 and % CAGR
  • TABLE 273: Latin America Historic Review for Immunodiagnostics by Geographic Region - Argentina, Brazil, Mexico and Rest of Latin America Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 274: Latin America 15-Year Perspective for Immunodiagnostics by Geographic Region - Percentage Breakdown of Value Sales for Argentina, Brazil, Mexico and Rest of Latin America Markets for Years 2015, 2025 & 2030
  • TABLE 275: Latin America Recent Past, Current & Future Analysis for Immunodiagnostics by Product Type - Reagents, Instruments and Software & Services - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 276: Latin America Historic Review for Immunodiagnostics by Product Type - Reagents, Instruments and Software & Services Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 277: Latin America 15-Year Perspective for Immunodiagnostics by Product Type - Percentage Breakdown of Value Sales for Reagents, Instruments and Software & Services for the Years 2015, 2025 & 2030
  • TABLE 278: Latin America Recent Past, Current & Future Analysis for Immunodiagnostics by Application - Oncology & Endocrinology, Bone & Mineral Diseases, Autoimmune Disorders, Cardiac Biomarkers, Drug Monitoring, Other Applications and Infectious Diseases - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 279: Latin America Historic Review for Immunodiagnostics by Application - Oncology & Endocrinology, Bone & Mineral Diseases, Autoimmune Disorders, Cardiac Biomarkers, Drug Monitoring, Other Applications and Infectious Diseases Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 280: Latin America 15-Year Perspective for Immunodiagnostics by Application - Percentage Breakdown of Value Sales for Oncology & Endocrinology, Bone & Mineral Diseases, Autoimmune Disorders, Cardiac Biomarkers, Drug Monitoring, Other Applications and Infectious Diseases for the Years 2015, 2025 & 2030
  • TABLE 281: Latin America Recent Past, Current & Future Analysis for Immunodiagnostics by End-Use - Hospitals, Clinical Laboratories, Academic & Research Institutes and Other End-Uses - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 282: Latin America Historic Review for Immunodiagnostics by End-Use - Hospitals, Clinical Laboratories, Academic & Research Institutes and Other End-Uses Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 283: Latin America 15-Year Perspective for Immunodiagnostics by End-Use - Percentage Breakdown of Value Sales for Hospitals, Clinical Laboratories, Academic & Research Institutes and Other End-Uses for the Years 2015, 2025 & 2030
  • TABLE 284: Latin America Recent Past, Current & Future Analysis for Immunodiagnostics by Technology - Enzyme-linked Immunosorbent Assay, Chemiluminescence Immunoassay, Fluorescent Immunoassay, Radioimmunoassay and Other Technologies - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 285: Latin America Historic Review for Immunodiagnostics by Technology - Enzyme-linked Immunosorbent Assay, Chemiluminescence Immunoassay, Fluorescent Immunoassay, Radioimmunoassay and Other Technologies Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 286: Latin America 15-Year Perspective for Immunodiagnostics by Technology - Percentage Breakdown of Value Sales for Enzyme-linked Immunosorbent Assay, Chemiluminescence Immunoassay, Fluorescent Immunoassay, Radioimmunoassay and Other Technologies for the Years 2015, 2025 & 2030
• ARGENTINA
  • TABLE 287: Argentina Recent Past, Current & Future Analysis for Immunodiagnostics by Product Type - Reagents, Instruments and Software & Services - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 288: Argentina Historic Review for Immunodiagnostics by Product Type - Reagents, Instruments and Software & Services Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 289: Argentina 15-Year Perspective for Immunodiagnostics by Product Type - Percentage Breakdown of Value Sales for Reagents, Instruments and Software & Services for the Years 2015, 2025 & 2030
  • TABLE 290: Argentina Recent Past, Current & Future Analysis for Immunodiagnostics by Application - Oncology & Endocrinology, Bone & Mineral Diseases, Autoimmune Disorders, Cardiac Biomarkers, Drug Monitoring, Other Applications and Infectious Diseases - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 291: Argentina Historic Review for Immunodiagnostics by Application - Oncology & Endocrinology, Bone & Mineral Diseases, Autoimmune Disorders, Cardiac Biomarkers, Drug Monitoring, Other Applications and Infectious Diseases Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 292: Argentina 15-Year Perspective for Immunodiagnostics by Application - Percentage Breakdown of Value Sales for Oncology & Endocrinology, Bone & Mineral Diseases, Autoimmune Disorders, Cardiac Biomarkers, Drug Monitoring, Other Applications and Infectious Diseases for the Years 2015, 2025 & 2030
  • TABLE 293: Argentina Recent Past, Current & Future Analysis for Immunodiagnostics by End-Use - Hospitals, Clinical Laboratories, Academic & Research Institutes and Other End-Uses - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 294: Argentina Historic Review for Immunodiagnostics by End-Use - Hospitals, Clinical Laboratories, Academic & Research Institutes and Other End-Uses Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 295: Argentina 15-Year Perspective for Immunodiagnostics by End-Use - Percentage Breakdown of Value Sales for Hospitals, Clinical Laboratories, Academic & Research Institutes and Other End-Uses for the Years 2015, 2025 & 2030
  • TABLE 296: Argentina Recent Past, Current & Future Analysis for Immunodiagnostics by Technology - Enzyme-linked Immunosorbent Assay, Chemiluminescence Immunoassay, Fluorescent Immunoassay, Radioimmunoassay and Other Technologies - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 297: Argentina Historic Review for Immunodiagnostics by Technology - Enzyme-linked Immunosorbent Assay, Chemiluminescence Immunoassay, Fluorescent Immunoassay, Radioimmunoassay and Other Technologies Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 298: Argentina 15-Year Perspective for Immunodiagnostics by Technology - Percentage Breakdown of Value Sales for Enzyme-linked Immunosorbent Assay, Chemiluminescence Immunoassay, Fluorescent Immunoassay, Radioimmunoassay and Other Technologies for the Years 2015, 2025 & 2030
• BRAZIL
  • TABLE 299: Brazil Recent Past, Current & Future Analysis for Immunodiagnostics by Product Type - Reagents, Instruments and Software & Services - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 300: Brazil Historic Review for Immunodiagnostics by Product Type - Reagents, Instruments and Software & Services Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 301: Brazil 15-Year Perspective for Immunodiagnostics by Product Type - Percentage Breakdown of Value Sales for Reagents, Instruments and Software & Services for the Years 2015, 2025 & 2030
  • TABLE 302: Brazil Recent Past, Current & Future Analysis for Immunodiagnostics by Application - Oncology & Endocrinology, Bone & Mineral Diseases, Autoimmune Disorders, Cardiac Biomarkers, Drug Monitoring, Other Applications and Infectious Diseases - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 303: Brazil Historic Review for Immunodiagnostics by Application - Oncology & Endocrinology, Bone & Mineral Diseases, Autoimmune Disorders, Cardiac Biomarkers, Drug Monitoring, Other Applications and Infectious Diseases Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 304: Brazil 15-Year Perspective for Immunodiagnostics by Application - Percentage Breakdown of Value Sales for Oncology & Endocrinology, Bone & Mineral Diseases, Autoimmune Disorders, Cardiac Biomarkers, Drug Monitoring, Other Applications and Infectious Diseases for the Years 2015, 2025 & 2030
  • TABLE 305: Brazil Recent Past, Current & Future Analysis for Immunodiagnostics by End-Use - Hospitals, Clinical Laboratories, Academic & Research Institutes and Other End-Uses - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 306: Brazil Historic Review for Immunodiagnostics by End-Use - Hospitals, Clinical Laboratories, Academic & Research Institutes and Other End-Uses Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 307: Brazil 15-Year Perspective for Immunodiagnostics by End-Use - Percentage Breakdown of Value Sales for Hospitals, Clinical Laboratories, Academic & Research Institutes and Other End-Uses for the Years 2015, 2025 & 2030
  • TABLE 308: Brazil Recent Past, Current & Future Analysis for Immunodiagnostics by Technology - Enzyme-linked Immunosorbent Assay, Chemiluminescence Immunoassay, Fluorescent Immunoassay, Radioimmunoassay and Other Technologies - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 309: Brazil Historic Review for Immunodiagnostics by Technology - Enzyme-linked Immunosorbent Assay, Chemiluminescence Immunoassay, Fluorescent Immunoassay, Radioimmunoassay and Other Technologies Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 310: Brazil 15-Year Perspective for Immunodiagnostics by Technology - Percentage Breakdown of Value Sales for Enzyme-linked Immunosorbent Assay, Chemiluminescence Immunoassay, Fluorescent Immunoassay, Radioimmunoassay and Other Technologies for the Years 2015, 2025 & 2030
• MEXICO
  • TABLE 311: Mexico Recent Past, Current & Future Analysis for Immunodiagnostics by Product Type - Reagents, Instruments and Software & Services - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 312: Mexico Historic Review for Immunodiagnostics by Product Type - Reagents, Instruments and Software & Services Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 313: Mexico 15-Year Perspective for Immunodiagnostics by Product Type - Percentage Breakdown of Value Sales for Reagents, Instruments and Software & Services for the Years 2015, 2025 & 2030
  • TABLE 314: Mexico Recent Past, Current & Future Analysis for Immunodiagnostics by Application - Oncology & Endocrinology, Bone & Mineral Diseases, Autoimmune Disorders, Cardiac Biomarkers, Drug Monitoring, Other Applications and Infectious Diseases - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 315: Mexico Historic Review for Immunodiagnostics by Application - Oncology & Endocrinology, Bone & Mineral Diseases, Autoimmune Disorders, Cardiac Biomarkers, Drug Monitoring, Other Applications and Infectious Diseases Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 316: Mexico 15-Year Perspective for Immunodiagnostics by Application - Percentage Breakdown of Value Sales for Oncology & Endocrinology, Bone & Mineral Diseases, Autoimmune Disorders, Cardiac Biomarkers, Drug Monitoring, Other Applications and Infectious Diseases for the Years 2015, 2025 & 2030
  • TABLE 317: Mexico Recent Past, Current & Future Analysis for Immunodiagnostics by End-Use - Hospitals, Clinical Laboratories, Academic & Research Institutes and Other End-Uses - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 318: Mexico Historic Review for Immunodiagnostics by End-Use - Hospitals, Clinical Laboratories, Academic & Research Institutes and Other End-Uses Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 319: Mexico 15-Year Perspective for Immunodiagnostics by End-Use - Percentage Breakdown of Value Sales for Hospitals, Clinical Laboratories, Academic & Research Institutes and Other End-Uses for the Years 2015, 2025 & 2030
  • TABLE 320: Mexico Recent Past, Current & Future Analysis for Immunodiagnostics by Technology - Enzyme-linked Immunosorbent Assay, Chemiluminescence Immunoassay, Fluorescent Immunoassay, Radioimmunoassay and Other Technologies - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 321: Mexico Historic Review for Immunodiagnostics by Technology - Enzyme-linked Immunosorbent Assay, Chemiluminescence Immunoassay, Fluorescent Immunoassay, Radioimmunoassay and Other Technologies Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 322: Mexico 15-Year Perspective for Immunodiagnostics by Technology - Percentage Breakdown of Value Sales for Enzyme-linked Immunosorbent Assay, Chemiluminescence Immunoassay, Fluorescent Immunoassay, Radioimmunoassay and Other Technologies for the Years 2015, 2025 & 2030
• REST OF LATIN AMERICA
  • TABLE 323: Rest of Latin America Recent Past, Current & Future Analysis for Immunodiagnostics by Product Type - Reagents, Instruments and Software & Services - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 324: Rest of Latin America Historic Review for Immunodiagnostics by Product Type - Reagents, Instruments and Software & Services Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 325: Rest of Latin America 15-Year Perspective for Immunodiagnostics by Product Type - Percentage Breakdown of Value Sales for Reagents, Instruments and Software & Services for the Years 2015, 2025 & 2030
  • TABLE 326: Rest of Latin America Recent Past, Current & Future Analysis for Immunodiagnostics by Application - Oncology & Endocrinology, Bone & Mineral Diseases, Autoimmune Disorders, Cardiac Biomarkers, Drug Monitoring, Other Applications and Infectious Diseases - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 327: Rest of Latin America Historic Review for Immunodiagnostics by Application - Oncology & Endocrinology, Bone & Mineral Diseases, Autoimmune Disorders, Cardiac Biomarkers, Drug Monitoring, Other Applications and Infectious Diseases Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 328: Rest of Latin America 15-Year Perspective for Immunodiagnostics by Application - Percentage Breakdown of Value Sales for Oncology & Endocrinology, Bone & Mineral Diseases, Autoimmune Disorders, Cardiac Biomarkers, Drug Monitoring, Other Applications and Infectious Diseases for the Years 2015, 2025 & 2030
  • TABLE 329: Rest of Latin America Recent Past, Current & Future Analysis for Immunodiagnostics by End-Use - Hospitals, Clinical Laboratories, Academic & Research Institutes and Other End-Uses - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 330: Rest of Latin America Historic Review for Immunodiagnostics by End-Use - Hospitals, Clinical Laboratories, Academic & Research Institutes and Other End-Uses Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 331: Rest of Latin America 15-Year Perspective for Immunodiagnostics by End-Use - Percentage Breakdown of Value Sales for Hospitals, Clinical Laboratories, Academic & Research Institutes and Other End-Uses for the Years 2015, 2025 & 2030
  • TABLE 332: Rest of Latin America Recent Past, Current & Future Analysis for Immunodiagnostics by Technology - Enzyme-linked Immunosorbent Assay, Chemiluminescence Immunoassay, Fluorescent Immunoassay, Radioimmunoassay and Other Technologies - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 333: Rest of Latin America Historic Review for Immunodiagnostics by Technology - Enzyme-linked Immunosorbent Assay, Chemiluminescence Immunoassay, Fluorescent Immunoassay, Radioimmunoassay and Other Technologies Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 334: Rest of Latin America 15-Year Perspective for Immunodiagnostics by Technology - Percentage Breakdown of Value Sales for Enzyme-linked Immunosorbent Assay, Chemiluminescence Immunoassay, Fluorescent Immunoassay, Radioimmunoassay and Other Technologies for the Years 2015, 2025 & 2030
• MIDDLE EAST
  • Immunodiagnostics Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Middle East for 2025 (E)
  • TABLE 335: Middle East Recent Past, Current & Future Analysis for Immunodiagnostics by Geographic Region - Iran, Israel, Saudi Arabia, UAE and Rest of Middle East Markets - Independent Analysis of Annual Sales in US$ Million for Years 2024 through 2030 and % CAGR
  • TABLE 336: Middle East Historic Review for Immunodiagnostics by Geographic Region - Iran, Israel, Saudi Arabia, UAE and Rest of Middle East Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 337: Middle East 15-Year Perspective for Immunodiagnostics by Geographic Region - Percentage Breakdown of Value Sales for Iran, Israel, Saudi Arabia, UAE and Rest of Middle East Markets for Years 2015, 2025 & 2030
  • TABLE 338: Middle East Recent Past, Current & Future Analysis for Immunodiagnostics by Product Type - Reagents, Instruments and Software & Services - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 339: Middle East Historic Review for Immunodiagnostics by Product Type - Reagents, Instruments and Software & Services Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 340: Middle East 15-Year Perspective for Immunodiagnostics by Product Type - Percentage Breakdown of Value Sales for Reagents, Instruments and Software & Services for the Years 2015, 2025 & 2030
  • TABLE 341: Middle East Recent Past, Current & Future Analysis for Immunodiagnostics by Application - Oncology & Endocrinology, Bone & Mineral Diseases, Autoimmune Disorders, Cardiac Biomarkers, Drug Monitoring, Other Applications and Infectious Diseases - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 342: Middle East Historic Review for Immunodiagnostics by Application - Oncology & Endocrinology, Bone & Mineral Diseases, Autoimmune Disorders, Cardiac Biomarkers, Drug Monitoring, Other Applications and Infectious Diseases Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 343: Middle East 15-Year Perspective for Immunodiagnostics by Application - Percentage Breakdown of Value Sales for Oncology & Endocrinology, Bone & Mineral Diseases, Autoimmune Disorders, Cardiac Biomarkers, Drug Monitoring, Other Applications and Infectious Diseases for the Years 2015, 2025 & 2030
  • TABLE 344: Middle East Recent Past, Current & Future Analysis for Immunodiagnostics by End-Use - Hospitals, Clinical Laboratories, Academic & Research Institutes and Other End-Uses - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 345: Middle East Historic Review for Immunodiagnostics by End-Use - Hospitals, Clinical Laboratories, Academic & Research Institutes and Other End-Uses Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 346: Middle East 15-Year Perspective for Immunodiagnostics by End-Use - Percentage Breakdown of Value Sales for Hospitals, Clinical Laboratories, Academic & Research Institutes and Other End-Uses for the Years 2015, 2025 & 2030
  • TABLE 347: Middle East Recent Past, Current & Future Analysis for Immunodiagnostics by Technology - Enzyme-linked Immunosorbent Assay, Chemiluminescence Immunoassay, Fluorescent Immunoassay, Radioimmunoassay and Other Technologies - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 348: Middle East Historic Review for Immunodiagnostics by Technology - Enzyme-linked Immunosorbent Assay, Chemiluminescence Immunoassay, Fluorescent Immunoassay, Radioimmunoassay and Other Technologies Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 349: Middle East 15-Year Perspective for Immunodiagnostics by Technology - Percentage Breakdown of Value Sales for Enzyme-linked Immunosorbent Assay, Chemiluminescence Immunoassay, Fluorescent Immunoassay, Radioimmunoassay and Other Technologies for the Years 2015, 2025 & 2030
• IRAN
  • TABLE 350: Iran Recent Past, Current & Future Analysis for Immunodiagnostics by Product Type - Reagents, Instruments and Software & Services - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 351: Iran Historic Review for Immunodiagnostics by Product Type - Reagents, Instruments and Software & Services Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 352: Iran 15-Year Perspective for Immunodiagnostics by Product Type - Percentage Breakdown of Value Sales for Reagents, Instruments and Software & Services for the Years 2015, 2025 & 2030
  • TABLE 353: Iran Recent Past, Current & Future Analysis for Immunodiagnostics by Application - Oncology & Endocrinology, Bone & Mineral Diseases, Autoimmune Disorders, Cardiac Biomarkers, Drug Monitoring, Other Applications and Infectious Diseases - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 354: Iran Historic Review for Immunodiagnostics by Application - Oncology & Endocrinology, Bone & Mineral Diseases, Autoimmune Disorders, Cardiac Biomarkers, Drug Monitoring, Other Applications and Infectious Diseases Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 355: Iran 15-Year Perspective for Immunodiagnostics by Application - Percentage Breakdown of Value Sales for Oncology & Endocrinology, Bone & Mineral Diseases, Autoimmune Disorders, Cardiac Biomarkers, Drug Monitoring, Other Applications and Infectious Diseases for the Years 2015, 2025 & 2030
  • TABLE 356: Iran Recent Past, Current & Future Analysis for Immunodiagnostics by End-Use - Hospitals, Clinical Laboratories, Academic & Research Institutes and Other End-Uses - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 357: Iran Historic Review for Immunodiagnostics by End-Use - Hospitals, Clinical Laboratories, Academic & Research Institutes and Other End-Uses Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 358: Iran 15-Year Perspective for Immunodiagnostics by End-Use - Percentage Breakdown of Value Sales for Hospitals, Clinical Laboratories, Academic & Research Institutes and Other End-Uses for the Years 2015, 2025 & 2030
  • TABLE 359: Iran Recent Past, Current & Future Analysis for Immunodiagnostics by Technology - Enzyme-linked Immunosorbent Assay, Chemiluminescence Immunoassay, Fluorescent Immunoassay, Radioimmunoassay and Other Technologies - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 360: Iran Historic Review for Immunodiagnostics by Technology - Enzyme-linked Immunosorbent Assay, Chemiluminescence Immunoassay, Fluorescent Immunoassay, Radioimmunoassay and Other Technologies Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 361: Iran 15-Year Perspective for Immunodiagnostics by Technology - Percentage Breakdown of Value Sales for Enzyme-linked Immunosorbent Assay, Chemiluminescence Immunoassay, Fluorescent Immunoassay, Radioimmunoassay and Other Technologies for the Years 2015, 2025 & 2030
• ISRAEL
  • TABLE 362: Israel Recent Past, Current & Future Analysis for Immunodiagnostics by Product Type - Reagents, Instruments and Software & Services - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 363: Israel Historic Review for Immunodiagnostics by Product Type - Reagents, Instruments and Software & Services Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 364: Israel 15-Year Perspective for Immunodiagnostics by Product Type - Percentage Breakdown of Value Sales for Reagents, Instruments and Software & Services for the Years 2015, 2025 & 2030
  • TABLE 365: Israel Recent Past, Current & Future Analysis for Immunodiagnostics by Application - Oncology & Endocrinology, Bone & Mineral Diseases, Autoimmune Disorders, Cardiac Biomarkers, Drug Monitoring, Other Applications and Infectious Diseases - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 366: Israel Historic Review for Immunodiagnostics by Application - Oncology & Endocrinology, Bone & Mineral Diseases, Autoimmune Disorders, Cardiac Biomarkers, Drug Monitoring, Other Applications and Infectious Diseases Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 367: Israel 15-Year Perspective for Immunodiagnostics by Application - Percentage Breakdown of Value Sales for Oncology & Endocrinology, Bone & Mineral Diseases, Autoimmune Disorders, Cardiac Biomarkers, Drug Monitoring, Other Applications and Infectious Diseases for the Years 2015, 2025 & 2030
  • TABLE 368: Israel Recent Past, Current & Future Analysis for Immunodiagnostics by End-Use - Hospitals, Clinical Laboratories, Academic & Research Institutes and Other End-Uses - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 369: Israel Historic Review for Immunodiagnostics by End-Use - Hospitals, Clinical Laboratories, Academic & Research Institutes and Other End-Uses Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 370: Israel 15-Year Perspective for Immunodiagnostics by End-Use - Percentage Breakdown of Value Sales for Hospitals, Clinical Laboratories, Academic & Research Institutes and Other End-Uses for the Years 2015, 2025 & 2030
  • TABLE 371: Israel Recent Past, Current & Future Analysis for Immunodiagnostics by Technology - Enzyme-linked Immunosorbent Assay, Chemiluminescence Immunoassay, Fluorescent Immunoassay, Radioimmunoassay and Other Technologies - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 372: Israel Historic Review for Immunodiagnostics by Technology - Enzyme-linked Immunosorbent Assay, Chemiluminescence Immunoassay, Fluorescent Immunoassay, Radioimmunoassay and Other Technologies Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 373: Israel 15-Year Perspective for Immunodiagnostics by Technology - Percentage Breakdown of Value Sales for Enzyme-linked Immunosorbent Assay, Chemiluminescence Immunoassay, Fluorescent Immunoassay, Radioimmunoassay and Other Technologies for the Years 2015, 2025 & 2030
• SAUDI ARABIA
  • TABLE 374: Saudi Arabia Recent Past, Current & Future Analysis for Immunodiagnostics by Product Type - Reagents, Instruments and Software & Services - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 375: Saudi Arabia Historic Review for Immunodiagnostics by Product Type - Reagents, Instruments and Software & Services Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 376: Saudi Arabia 15-Year Perspective for Immunodiagnostics by Product Type - Percentage Breakdown of Value Sales for Reagents, Instruments and Software & Services for the Years 2015, 2025 & 2030
  • TABLE 377: Saudi Arabia Recent Past, Current & Future Analysis for Immunodiagnostics by Application - Oncology & Endocrinology, Bone & Mineral Diseases, Autoimmune Disorders, Cardiac Biomarkers, Drug Monitoring, Other Applications and Infectious Diseases - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 378: Saudi Arabia Historic Review for Immunodiagnostics by Application - Oncology & Endocrinology, Bone & Mineral Diseases, Autoimmune Disorders, Cardiac Biomarkers, Drug Monitoring, Other Applications and Infectious Diseases Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 379: Saudi Arabia 15-Year Perspective for Immunodiagnostics by Application - Percentage Breakdown of Value Sales for Oncology & Endocrinology, Bone & Mineral Diseases, Autoimmune Disorders, Cardiac Biomarkers, Drug Monitoring, Other Applications and Infectious Diseases for the Years 2015, 2025 & 2030
  • TABLE 380: Saudi Arabia Recent Past, Current & Future Analysis for Immunodiagnostics by End-Use - Hospitals, Clinical Laboratories, Academic & Research Institutes and Other End-Uses - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 381: Saudi Arabia Historic Review for Immunodiagnostics by End-Use - Hospitals, Clinical Laboratories, Academic & Research Institutes and Other End-Uses Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 382: Saudi Arabia 15-Year Perspective for Immunodiagnostics by End-Use - Percentage Breakdown of Value Sales for Hospitals, Clinical Laboratories, Academic & Research Institutes and Other End-Uses for the Years 2015, 2025 & 2030
  • TABLE 383: Saudi Arabia Recent Past, Current & Future Analysis for Immunodiagnostics by Technology - Enzyme-linked Immunosorbent Assay, Chemiluminescence Immunoassay, Fluorescent Immunoassay, Radioimmunoassay and Other Technologies - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 384: Saudi Arabia Historic Review for Immunodiagnostics by Technology - Enzyme-linked Immunosorbent Assay, Chemiluminescence Immunoassay, Fluorescent Immunoassay, Radioimmunoassay and Other Technologies Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 385: Saudi Arabia 15-Year Perspective for Immunodiagnostics by Technology - Percentage Breakdown of Value Sales for Enzyme-linked Immunosorbent Assay, Chemiluminescence Immunoassay, Fluorescent Immunoassay, Radioimmunoassay and Other Technologies for the Years 2015, 2025 & 2030
• UNITED ARAB EMIRATES
  • TABLE 386: UAE Recent Past, Current & Future Analysis for Immunodiagnostics by Product Type - Reagents, Instruments and Software & Services - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 387: UAE Historic Review for Immunodiagnostics by Product Type - Reagents, Instruments and Software & Services Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 388: UAE 15-Year Perspective for Immunodiagnostics by Product Type - Percentage Breakdown of Value Sales for Reagents, Instruments and Software & Services for the Years 2015, 2025 & 2030
  • TABLE 389: UAE Recent Past, Current & Future Analysis for Immunodiagnostics by Application - Oncology & Endocrinology, Bone & Mineral Diseases, Autoimmune Disorders, Cardiac Biomarkers, Drug Monitoring, Other Applications and Infectious Diseases - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 390: UAE Historic Review for Immunodiagnostics by Application - Oncology & Endocrinology, Bone & Mineral Diseases, Autoimmune Disorders, Cardiac Biomarkers, Drug Monitoring, Other Applications and Infectious Diseases Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 391: UAE 15-Year Perspective for Immunodiagnostics by Application - Percentage Breakdown of Value Sales for Oncology & Endocrinology, Bone & Mineral Diseases, Autoimmune Disorders, Cardiac Biomarkers, Drug Monitoring, Other Applications and Infectious Diseases for the Years 2015, 2025 & 2030
  • TABLE 392: UAE Recent Past, Current & Future Analysis for Immunodiagnostics by End-Use - Hospitals, Clinical Laboratories, Academic & Research Institutes and Other End-Uses - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 393: UAE Historic Review for Immunodiagnostics by End-Use - Hospitals, Clinical Laboratories, Academic & Research Institutes and Other End-Uses Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 394: UAE 15-Year Perspective for Immunodiagnostics by End-Use - Percentage Breakdown of Value Sales for Hospitals, Clinical Laboratories, Academic & Research Institutes and Other End-Uses for the Years 2015, 2025 & 2030
  • TABLE 395: UAE Recent Past, Current & Future Analysis for Immunodiagnostics by Technology - Enzyme-linked Immunosorbent Assay, Chemiluminescence Immunoassay, Fluorescent Immunoassay, Radioimmunoassay and Other Technologies - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 396: UAE Historic Review for Immunodiagnostics by Technology - Enzyme-linked Immunosorbent Assay, Chemiluminescence Immunoassay, Fluorescent Immunoassay, Radioimmunoassay and Other Technologies Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 397: UAE 15-Year Perspective for Immunodiagnostics by Technology - Percentage Breakdown of Value Sales for Enzyme-linked Immunosorbent Assay, Chemiluminescence Immunoassay, Fluorescent Immunoassay, Radioimmunoassay and Other Technologies for the Years 2015, 2025 & 2030
• REST OF MIDDLE EAST
  • TABLE 398: Rest of Middle East Recent Past, Current & Future Analysis for Immunodiagnostics by Product Type - Reagents, Instruments and Software & Services - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 399: Rest of Middle East Historic Review for Immunodiagnostics by Product Type - Reagents, Instruments and Software & Services Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 400: Rest of Middle East 15-Year Perspective for Immunodiagnostics by Product Type - Percentage Breakdown of Value Sales for Reagents, Instruments and Software & Services for the Years 2015, 2025 & 2030
  • TABLE 401: Rest of Middle East Recent Past, Current & Future Analysis for Immunodiagnostics by Application - Oncology & Endocrinology, Bone & Mineral Diseases, Autoimmune Disorders, Cardiac Biomarkers, Drug Monitoring, Other Applications and Infectious Diseases - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 402: Rest of Middle East Historic Review for Immunodiagnostics by Application - Oncology & Endocrinology, Bone & Mineral Diseases, Autoimmune Disorders, Cardiac Biomarkers, Drug Monitoring, Other Applications and Infectious Diseases Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 403: Rest of Middle East 15-Year Perspective for Immunodiagnostics by Application - Percentage Breakdown of Value Sales for Oncology & Endocrinology, Bone & Mineral Diseases, Autoimmune Disorders, Cardiac Biomarkers, Drug Monitoring, Other Applications and Infectious Diseases for the Years 2015, 2025 & 2030
  • TABLE 404: Rest of Middle East Recent Past, Current & Future Analysis for Immunodiagnostics by End-Use - Hospitals, Clinical Laboratories, Academic & Research Institutes and Other End-Uses - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 405: Rest of Middle East Historic Review for Immunodiagnostics by End-Use - Hospitals, Clinical Laboratories, Academic & Research Institutes and Other End-Uses Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 406: Rest of Middle East 15-Year Perspective for Immunodiagnostics by End-Use - Percentage Breakdown of Value Sales for Hospitals, Clinical Laboratories, Academic & Research Institutes and Other End-Uses for the Years 2015, 2025 & 2030
  • TABLE 407: Rest of Middle East Recent Past, Current & Future Analysis for Immunodiagnostics by Technology - Enzyme-linked Immunosorbent Assay, Chemiluminescence Immunoassay, Fluorescent Immunoassay, Radioimmunoassay and Other Technologies - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 408: Rest of Middle East Historic Review for Immunodiagnostics by Technology - Enzyme-linked Immunosorbent Assay, Chemiluminescence Immunoassay, Fluorescent Immunoassay, Radioimmunoassay and Other Technologies Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 409: Rest of Middle East 15-Year Perspective for Immunodiagnostics by Technology - Percentage Breakdown of Value Sales for Enzyme-linked Immunosorbent Assay, Chemiluminescence Immunoassay, Fluorescent Immunoassay, Radioimmunoassay and Other Technologies for the Years 2015, 2025 & 2030
• AFRICA
  • Immunodiagnostics Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Africa for 2025 (E)
  • TABLE 410: Africa Recent Past, Current & Future Analysis for Immunodiagnostics by Product Type - Reagents, Instruments and Software & Services - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 411: Africa Historic Review for Immunodiagnostics by Product Type - Reagents, Instruments and Software & Services Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 412: Africa 15-Year Perspective for Immunodiagnostics by Product Type - Percentage Breakdown of Value Sales for Reagents, Instruments and Software & Services for the Years 2015, 2025 & 2030
  • TABLE 413: Africa Recent Past, Current & Future Analysis for Immunodiagnostics by Application - Oncology & Endocrinology, Bone & Mineral Diseases, Autoimmune Disorders, Cardiac Biomarkers, Drug Monitoring, Other Applications and Infectious Diseases - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 414: Africa Historic Review for Immunodiagnostics by Application - Oncology & Endocrinology, Bone & Mineral Diseases, Autoimmune Disorders, Cardiac Biomarkers, Drug Monitoring, Other Applications and Infectious Diseases Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 415: Africa 15-Year Perspective for Immunodiagnostics by Application - Percentage Breakdown of Value Sales for Oncology & Endocrinology, Bone & Mineral Diseases, Autoimmune Disorders, Cardiac Biomarkers, Drug Monitoring, Other Applications and Infectious Diseases for the Years 2015, 2025 & 2030
  • TABLE 416: Africa Recent Past, Current & Future Analysis for Immunodiagnostics by End-Use - Hospitals, Clinical Laboratories, Academic & Research Institutes and Other End-Uses - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 417: Africa Historic Review for Immunodiagnostics by End-Use - Hospitals, Clinical Laboratories, Academic & Research Institutes and Other End-Uses Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 418: Africa 15-Year Perspective for Immunodiagnostics by End-Use - Percentage Breakdown of Value Sales for Hospitals, Clinical Laboratories, Academic & Research Institutes and Other End-Uses for the Years 2015, 2025 & 2030
  • TABLE 419: Africa Recent Past, Current & Future Analysis for Immunodiagnostics by Technology - Enzyme-linked Immunosorbent Assay, Chemiluminescence Immunoassay, Fluorescent Immunoassay, Radioimmunoassay and Other Technologies - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 420: Africa Historic Review for Immunodiagnostics by Technology - Enzyme-linked Immunosorbent Assay, Chemiluminescence Immunoassay, Fluorescent Immunoassay, Radioimmunoassay and Other Technologies Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 421: Africa 15-Year Perspective for Immunodiagnostics by Technology - Percentage Breakdown of Value Sales for Enzyme-linked Immunosorbent Assay, Chemiluminescence Immunoassay, Fluorescent Immunoassay, Radioimmunoassay and Other Technologies for the Years 2015, 2025 & 2030

IV. COMPETITION